Dr. Emily Aaronson is Associate Chief Quality Officer at Massachusetts General Hospital, Assistant Professor of Emergency Medicine at Harvard Medical School and an attending physician in the Department of Emergency Medicine at MGH. She also serves as an Associate Medical Director for CRICO, the risk management foundation of the Harvard medical institutions. Prior to this, Dr. Aaronson was a resident in the Harvard Affiliated Emergency Medicine Residency, where she served as a chief resident. She then completed the Harvard Medical School fellowship in Patient Safety and Quality Improvement, and a Masters in Public Health at the Harvard School of Public Health. Before medical school, Dr. Aaronson worked in healthcare consulting for the consulting arm of the Advisory Board Company. In her role as Assistant Chief Quality Officer at MGH, Dr. Aaronson plays a central role in the quality and safety leadership team at the institution. She has worked on projects that intersect quality measurement and performance improvement including helping to lead the institutional efforts to improve performance on Sepsis, and spearheading improvements in the quality of care for patients with Serious Illness in the Emergency Department. In her role as a physician in the center for quality and safety she is a part of the team that reviews and investigates serious events throughout the hospital, and helps lead the team that works on harmonizing quality across the MGH affiliated hospitals.
Melissa Abraham, in her role as the Director for the MGH Division of Clinical Research’s Research Ethics Consultation Unit, uses her 15 year background as a member and Chair of the Partners IRB and a fellow in Bioethics at HMS, to consult with investigators to improve the quality of IRB submissions and reviews, by discussing the ethical underpinnings of institutional and regulatory requirements with researchers, and assisting in the communication of QI, social science and behavioral research methods and practices to the IRB. She teaches bioethics at HMS and has a psychotherapy practice. Melissa has a degree in Epidemiology from the Harvard School of Public Health, and a doctorate in Clinical Psychology from Northwestern University Medical School.
Aalok Agarwala collaborates on the Operating Room Black Box project with Ariadne Labs to test new ways of gathering patient data and environmental information to reduce errors, improve quality, and better understand team dynamics in the operating room. This project will be piloted at Massachusetts General Hospital. Dr. Agarwala also collaborates with Ariadne Labs and the Emergency Manual Implementation Collaborative in the national effort to increase implementation of the Operating Room Crisis Checklist.
Shahed received his BS in Biomedical Engineering and MS in Public Health from Johns Hopkins University, and his MD from Stanford University. From 2010-2011, he served as an Associate Faculty member at the Johns Hopkins School of Public Health, Department of International Health. In 2014, he co-founded Noora Health, and since then have been committed to driving home a big idea- that “it takes a family” to improve how healthcare is delivered. Noora Health partners with health systems in India and Bangladesh to improve the training and engagement of family members throughout the process of care delivery. Noora is present across 150+ hospitals, trained 800,000+ family caregivers, and evidence suggests that its programs improves health behavior change and certain health outcomes.
Rather than pursuing medical practice in the US, Shahed has dedicated himself to leading Noora’s mission, working on the ground alongside its talented and growing team in India. Before Noora, his experiences focused on a range of projects including the health of incarcerated populations in the US and developing low-cost technologies for improved diagnostics in resource poor settings. He currently resides in Bangalore, India with his partner and their two energetic dogs.
Eric Alper, MD is VP/Chief Quality Officer and Chief Clinical Informatics Officer at UMass Memorial Health Care in Worcester, MA. After Brown, he attended medical school and did his residency in Internal medicine at UMass in Worcester. He became the first Hospitalist and built the hospitalist program which now employs over 60 physicians. He led the education of medical students on their 3rd year Medicine clerkship for 10 years. After the release of the IOM report To Err is Human, he began work on patient safety and quality; he became Patient Safety Officer for UMass Memorial Health Care and worked on safety / quality improvement in that role for 3 years. Recognizing the need to improve systems to improve quality, he spent the next decade working in the Healthcare IT space. He worked for a year with UpToDate on building evidence based, standard order sets. He then returned to UMass, participated in the implementation of Siemens Soarian. With the conclusion of that project, he transitioned to Lifespan hospitals in Providence, RI to lead the implementation of Epic for 1300 physicians and 13000 employees. Subsequently, when UMass Memorial announced that it was going to implement Epic, he returned there and helped lead the implementation for its 2200 physicians and 14,000 employees. He had driven the formation of an effective governance structure for effective decision-making. His teams have developed hundreds of evidence-based order-sets and alerts, effective inpatient, ambulatory and other workflows. He has led the rollout of a number of other initiatives like e-prescribing of controlled substances, improvements in opioid prescribing, exchange of information with Epic and non-Epic EHRs, patient engagement, and many other initiatives. In 2018, he was appointed Chief Quality Officer, where he is leveraging Epic to improve patient care, patient experience, and quality of care. He has expertise in usability design, decision support, interoperability, quality measurement, end user adoption, and quality improvement methodology.
Dr. Arbour is a physician anthropologist who implements and evaluates interdisciplinary interventions to promote child development globally, using a combination of experimental, ethnographic and quality improvement methodologies. She has particular interests in methods for adapting evidence-based practices across diverse contexts and populations, and in scale.
Dr. Arbour’s expertise includes adapting continuous quality improvement methods (CQI) to a diversity of disciplines and contexts to improve clinical, public health and education outcomes. She leads integration of CQI methods in:
• the US Department of Maternal and Child Health’s first national quality improvement collaborative for home visiting services (HV CoIIN, Home Visiting Collaboration for Improvement and Innovation Network),
• the adaptation and spread of Project DULCE, an intervention to address social determinants of health and promote understanding of healthy development among families with infants 0 to 6 months in pediatric clinics in 3 states,
• a community-level collaboration aimed at improving child development in two high-poverty neighborhoods in NYC
• a school-based intervention to improve children’s health and learning in public preschools in Chile (Un Buen Comienzo, A Good Start), conducted as a cluster-randomized trial in a first phase (2008-2011) and quasi-experimental design in a latter expansion (2011-present).
She has led quality improvement capacity-building efforts, formal curriculum development and delivery with professionals, paraprofessionals and community members. She co-designed and teaches the DOHVE CQI practicum for MIECHV state leads.
Dr. Arbour holds a BA in Biological Anthropology from Swarthmore College, an MD from Harvard Medical School and an MPH from the Harvard School of Public Health.
Alex Arriaga is an Assistant Professor of Anaesthesia at Harvard Medical School and Anesthesiologist for the Brigham and Women’s Hospital. He completed his undergraduate studies from Columbia University and graduated from medical school with Honors in Research from Cornell University. He completed two years of categorical general surgery residency at Thomas Jefferson University Hospital. He has Master of Public Health and Doctor of Science degrees from Harvard University. He completed his clinical residency in anesthesiology at the Brigham and Women’s Hospital with Distinction in Research. He was a member of the faculty at the University of Pennsylvania for two years. He has presented locally and nationally. Dr. Arriaga has over forty co-authored publications, including two book chapters as senior author. His peer-reviewed published work includes first-author original research study in the New England Journal of Medicine (NEJM), the Annals of Surgery, and Anesthesiology. He is a member of the Advisory Board of the Center for Diversity and Inclusion of the Brigham and Women’s Hospital. He is an Affiliate Faculty member for the Center for Surgery and Public Health.
His academic interests include health services research in crisis management, patient safety, perioperative care, and quality improvement, with a focus on the fields of surgery and anesthesiology. His current work includes efforts to understand the perioperative implications of intraoperative critical events, as well as the delivery of interventions aimed to improve outcomes for both patients and providers. He is also involved in efforts to promote diversity, equity and inclusion. His work also includes medication education research to understand how to take data driven approaches, including those that intersect patient safety, towards improving medical education and clinical care.
Stan Ashley is a GI Surgeon with interests in GME, CPD, and quality improvement. He has served as a member of a Ariadne task force focused on reducing patient safety risk from health systems expansion and currently is involved with the surgical coaching project.
Dr. Michael L. Barnett is Assistant Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health and a primary care physician at Brigham and Women’s Hospital. Dr. Barnett received his MD from Harvard Medical School and completed a residency and fellowship in primary care and general internal medicine at Brigham and Women’s Hospital. Dr. Barnett’s research focuses on understanding and improving the health care delivery system with a specific interest in the opioid crisis as well as studying innovative models for health care payment and care delivery. His research has received best research of the year awards from the Society of General Internal Medicine and AcademyHealth and has also been featured in national media including the New York Times, National Public Radio and CNN. He is also the recipient of a Career Development Award from the National Institute on Aging.
Salma Batool-Anwar’s research focuses on integrating palliative care services for critically ill patients in intensive care units. In addition, she is interested in studying the public health impact of variety of sleep disorders.
As a Hospitalist Physician and a Physician Advisor for Case Management at Massachusetts General Hospital, I work in several capacities to optimize patient flow and quality of care. In my prior role as a Director of Quality Improvement at the VA Boston, I had a unique vantage point as physician in both a hospital and a skilled-nursing facility to improve care transitions by implementing best practices. I completed residency in Internal Medicine and Global Health at the University of Pittsburgh Medical Center and then fellowship in General Internal Medicine at the Brigham and Women’s Hospital/Harvard Medical School. I have leveraged my research training in the QI and operations space, focusing on flow, length of stay and high-risk care transitions. I am an Instructor in Medicine at Harvard Medical School.
After completing combined fellowships in community health leadership and addiction medicine, Dr. Benjamin Bearnot is now a research faculty member in the Division of General Internal Medicine and the Mongan Institute in the Department of Medicine at Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School. His clinical research and implementation science training focuses on addressing the devastating substance use disorder and drug overdose epidemics facing New England and the United States. Dr. Bearnot is supported by a career development award from the National Institute on Drug Abuse to study the serious bacterial complications of opioid use disorder to develop and evaluate new treatment strategies for individuals with infectious complications of injection drug use.
As the Chief Medical Officer at Ariadne Labs, Evan Benjamin, MD, MS, FACP, provides oversight, guidance, and support to Ariadne Labs research faculty, ensuring that Ariadne’s findings are supported by rigorous evidence and result in clinically meaningful change. Evan mentors faculty and research scientists and works with individuals to enhance faculty research. In addition, Evan works in close collaboration with Ariadne’s founder, Dr. Atul Gawande, to develop and expand Ariadne’s strategic partnerships, and to raise the Ariadne Labs profile as a global leader in health systems innovation.
Prior to becoming CMO at Ariadne Labs, Evan was Senior Vice President for Population Health and Quality, Baystate Health, a $2B revenue integrated delivery system in Massachusetts where he oversaw clinical quality, patient safety, population health, infection control, a 100 physician primary care practice, and Information Technology for the 5 hospital system. He was responsible for bringing reliability and efficiency to the health system using modern tools of improvement science.
He is an Associate Professor of Medicine at Harvard Medical School with a secondary appointment at the Harvard T.H. Chan School of Public Health and is also an Adjunct Professor of Medicine at Tufts University. He is active in scholarly research in healthcare delivery and speaks and consults nationally on issues related to improving healthcare delivery. Evan is faculty for the Institute for Healthcare Improvement (IHI) where he teaches leadership and improvement and sits on numerous national boards and healthcare panels including the National Academy of Medicine, the American Hospital Association, CMS and others. He currently serves as a board member for the UMass Memorial Health Care System.
Evan received a BA in Chemistry from Williams College, an MD from Case Western Reserve University, and an MS in Healthcare Delivery Science from Dartmouth College. He completed an internal medicine residency at Yale-New Haven Hospital.
Prof. Peter Berman (M.Sc, Ph.D) is a health economist with forty years of experience in research, policy analysis and development, and training and education in global health. Prof. Berman is Professor and Director, School of Population and Public Health, University of British Columbia in Vancouver Canada, and Adjunct Professor in Global Health at Harvard T. H. Chan School of Public Health, Harvard University, as of January 1, 2019.
He relocated to Vancouver, Canada after a quarter century on the faculty of Harvard University, most recently as Professor of the Practice of Global Health Systems and Economics at Harvard T. H. Chan School of Public Health (HSPH) in Boston, USA. He is also affliated as Adjunct Professor at the Public Health Foundation of India (PHFI) in New Delhi, India and as advisor to the China National Health Development Research Center for health care financing and health accounts.
Prof. Berman was the founding faculty director of Harvard Chan’s new Doctor of Public Health degree and has been actively engaged in graduate education reform in global public health at Harvard. In recent years, Prof. Berman has led several innovative research projects on developing primary care systems, strengthening service delivery, and improving health care financing mechanisms for better outcomes, with a focus on work in Ethiopia, India, and Malaysia.
With the World Bank from 2004-2011, Prof. Berman spent four years in the Bank’s New Delhi office as Lead Economist for Health, Nutrition, and Population. There he oversaw a portfolio of almost $2 billion in projects and research. In Washington, D.C from 2008, he was Lead Health Economist in the HNP anchor department and Practice Leader for the World Bank’s Health Systems Global Expert Team. He led analytical work on health systems analysis and strategic approaches to improving service delivery.
Previously at Harvard Prof. Berman was the founding Director of the International Health Systems Program in the Population and International Health Department. He is the author or editor of five books on global health economics and policy and more than 50 academic papers in his field and numerous other working papers and reports. He has led and/or participated in major field programs in all regions of the developing world.
Prof. Berman’s specific areas of work include analysis of health systems performance and the design of reform strategies; assessment of the supply side of health care delivery and the role of private health care provision in health systems and development of strategies to improve outcomes through public-private sector collaboration. He pioneered the development and use of national health accounts as a policy and planning tool in developing countries. Prof. Berman has worked extensively on health system reform and health care development issues in a number of countries including Egypt, India, Colombia, Indonesia, and Poland. He has also worked for extended periods of residency and field work in Indonesia and India. He is co-author of Getting Health Reform Right: A Guide to Improving Performance and Equity (Roberts, et al, Oxford University Press, 2008), co-editor of the Guide to the Production of National Health Accounts (World Bank, World Health Organization, and USAID, 2003), and co-editor of Berman and Khan, Paying for India’s Health Care (Sage, 1993).
Rachelle Bernacki, MD, MS, is the Director of Quality Initiatives in the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute. Dr. Bernacki played a key role in developing the Serious Illness Care Program at Ariadne Labs, which has developed a standardized approach for ensuring clinicians conduct discussions about end-of-life values and goals with seriously ill patients and their families. Dr. Bernacki is the faculty development lead in the Serious Illness Community of Practice that nationally scales communication, implementation, and training efforts to strengthen health systems with innovative and sustainable solutions in serious illness care. She also directed the Dana-Farber Cancer Institute randomized controlled trial testing the Serious Illness Care Program, as well as implemented and adapted the program for high-risk primary care patients. Together with Zara Cooper, she recently started the BWH Center for Geriatric Surgery, which identifies vulnerable surgical patients through preoperative frailty screening and symptom assessments and creates clinical pathways tailored to meet their individual needs.
Dr. Bernacki is board certified in Palliative Medicine, Geriatrics, and Internal Medicine and a Fellow of both the American Academy of Hospice and Palliative Medicine (AAHPM) and the American Geriatrics Society. She serves on the Board of Directors of AAHPM and is a 2015 Cambia Sojourns Leadership Scholar. Dr. Bernacki received her B.S. from Cornell University, her M.S. from the University of Chicago where she completed the Robert Wood Johnson Clinical Scholars Program, and her M.D. from Johns Hopkins University School of Medicine.
As President and CEO at the National Institute for Children’s Health Quality (NICHQ), Scott leads initiatives aimed at driving change to improve children’s health. He has extensive experience working to enhance the health of children and families across academic, clinical, nonprofit and public health settings. Scott is a nationally recognized expert in quality improvement science and has published extensively. Prior to joining NICHQ, he spent 14 years at the March of Dimes National Office serving as Senior Vice President of Chapter Programs and the Deputy Medical Officer. Scott is Editor and Co-Author of “Toward Improving the Outcome of Pregnancy III: Enhancing Perinatal Health Through Quality, Safety and Performance Initiatives”. He is a board-certified pediatrician and pediatric emergency physician. Scott also completed a one-year White House Fellowship where he served as a Senior Advisor to the U.S. Secretary of Transportation. Scott is Co-Founder and Board Chair of The Progeria Research Foundation (PRF); he ensured PRF was a key force behind the Progeria gene discovery for this rare premature aging syndrome. He currently serves as Chair of the Patient-Centered Outcomes Research Institute’s Rare Disease Advisory Panel. He also serves on the Executive Committee of the AAP’s Council on Quality Improvement and Patient Safety. He has made multiple media appearances as an expert in perinatal health; Scott’s son Sam and family were featured in an HBO Emmy Award-winning documentary titled, “Life According to Sam.”
William Berry serves as the Strategic Advisor to the Chief Medical Officer and as Associate Director of Ariadne Labs. In 2012, together with Atul Gawande, he co-founded the Labs and served as Chief Medical Officer for its first five years. For the last year, he has been the Chief Implementation Officer and created the Implementation Platform. He began working with Dr. Gawande in 2005 and initially served as the Boston Project Director of the WHO Safe Surgery Saves Lives Program. Dr. Berry is a retired cardiothoracic surgeon with interests in patient safety and implementation in healthcare.
Amy Billett is the Principal Investigator of a project through Ariadne Labs called “Making It Easier to Care for Your Central Line at Home: A Standardized Process to Reduce Ambulatory Central Line Associated Bloodstream Infections (CLABSI).” This project is developing a model to decrease infection rates in pediatric hematology/oncology patients by ensuring that patients and their families develop the confidence and skills to perform best practice central line care at home correctly, every time with decreased distress. Preliminary results demonstrate that the project is feasible and well received by families, and suggest a decrease in infection rates. The team is now seeking to apply this model to high risk medication administration in the home.
As a Vice President in Premier’s Performance Services team since 2016, Dr. Biondolillo is responsible for strategic quality and population health initiatives to support members in value-based healthcare delivery and improvement. She has a proven track record of building long-term partnerships with providers and industry stakeholders in both public and private healthcare organizations. A healthcare quality and safety expert, she leads Premier’s 500-member Hospital Innovation and Improvement Network (HIIN) – a national quality collaborative.
Dr. Biondolillo is an academic physician executive with extensive management experience in ambulatory and hospital clinical operations in one of Harvard’s health systems. Her background and expertise includes public health, population health management, inpatient and outpatient quality/safety, and performance improvement. She previously served as Vice President of Population Health Management at the Connecticut Hospital Association where she directed the development and implementation of state and federal innovation efforts. Prior to that she supported the design of population health strategy at a Pioneer ACO founded by her Academic Health System. Dr. Biondolillo was CEO of the Urban Medical Group, a large ambulatory practice affiliated with Beth Israel Deaconess Medical Center in Boston, which specialized in adult medicine especially complex care and geriatrics. She served for four years as Associate Commissioner of the MA Department of Public Health, overseeing quality and safety as well as policy development related to the ACA and state health reform. Among her research initiatives, Dr. Biondolillo has served as Principal Investigator on a $3M Ambulatory Quality and Safety grant from the Agency for Healthcare Research and Quality. She serves as faculty for the Institute of Healthcare Improvement’s Complex Care initiative and on the American Hospital Association’s Quest for Quality Award Committee.
A graduate of the Tufts University School of Medicine, Dr. Biondolillo trained at MetroWest Medical Center and New England Medical Center in Boston and practiced primary care adult medicine for over 15 years in hospital, ambulatory, and post-acute (Skilled Nursing Facility, Rehabilitation and home) settings.
Asaf Bitton is a practicing primary care physician and assistant professor of medicine and health care policy at Harvard Medical School and Brigham & Women’s Hospital. He leads Ariadne Labs’ work around measuring and improving primary care performance as part of the Primary Health Care Performance Initiative (PHCPI), a joint effort with the Bill and Melinda Gates Foundation, The World Bank, The Results for Development Institute, and Ariadne Labs. Dr. Bitton is also Senior Advisor for the Comprehensive Primary Care Initiative Center for Medicare and Medicaid Innovation in Washington, DC.
Susan Block is a Senior Consultant to the Serious Illness Care Program at Ariadne Labs, a joint center for health care innovation at Brigham & Women’s Hospital and Harvard T.H. Chan School of Public Health and Professor of Psychiatry and Medicine at Harvard Medical School. She founded the program in 2011, and served as its Director until 2017. In addition, She was the Founding Chair of the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute and Brigham & Women’s Hospital, and Founding Co-Director of the Harvard Medical School Center for Palliative Care, a program she and her husband, Andy Billings led for 17 years. Dr. Block received her AB from Stanford University, her MD from Case Western Reserve University School of Medicine, and completed residencies in both internal medicine and psychiatry at Beth Israel Deaconess Medical Center in Boston. She is board-certified in both fields. Dr. Block has been a national leader in the development of the field of palliative medicine, has led major innovative educational and quality improvement projects in a variety of areas, is known internationally as an expert in medical education, faculty development, and health system change, and has contributed to research in medical education, palliative care, psychooncology, and health system change. She is the author of over 200 publications and has won numerous awards for education, research and leadership.
Rachel fell into geriatric medicine when she discovered the PACE model of care, a model that provides interdisciplinary care to frail elders to keep them living at home. She has spent most of her career in PACE (Program for All-Inclusive Care for Elders) and has been the Medical Director of the PACE program at Cambridge Health Alliance in Cambridge, MA and of Mercy LIFE in West Springfield, MA. In PACE she has collaborated with patients, families and a clinical team to coordinate the care of frail and complexly ill patients across home, hospital and nursing home settings. She also served as the Medical Director of the Senior Care Program at Cambridge Health Alliance, a post-acute and long-term care program. She completed her residency in Internal Medicine at Brigham and Women’s Hospital and is boarded in Internal Medicine and Hospice and Palliative Care. She completed the American Association for Physician Leadership Institute and the Faculty Scholars Program at the Geriatric Center of Excellence at Boston University. Currently she is the Medical Director of Pioneer Valley Hospice and Palliative Care and is the lead faculty consultant on Ariadne’s project addressing COVID-19 and the care of older adults in nursing homes.
Rachel is passionate about building a future where healthcare for frail elders is based on well-being; where our clinical interventions integrate older people more fully into our communities; and our systems of care prioritize and encourage agency, social connection and sense of purpose.
Dr. Brown is a pediatric radiologist at Boston Children’s Hospital and outgoing Director of the Hospital’s Institute for Professionalism and Ethical Practice (IPEP). He is an Associate Professor of Radiology at Harvard Medical School, and serves as faculty for medical students and Master’s students in the Center for Bioethics. Dr. Brown is an Associate Clinical Ethicist in the Boston Children’s Hospital Office of Ethics, Senior Scholar in its Academy for Teaching and Educational Innovation, past Chair of the RSNA Professionalism Committee, and an inaugural member of the Society for Pediatric Radiology Ethics Committee. He attended the University of Pennsylvania School of Medicine, completed Diagnostic Radiology residency at Massachusetts General Hospital, and fellowships in Pediatric Radiology and Pediatric Interventional Radiology at Boston Children’s Hospital.
Dr. Brown received a 2006 Children’s Hospital Faculty Career Development Award, and he was named an Eleanor and Miles Shore 50th Anniversary Scholar in Medicine at Harvard Medical School. He is the inaugural recipient of the American Roentgen Ray Society Leonard Berlin Scholarship in Medical Professionalism, and a recipient of grants from the Kornfeld Program in Bioethics and Patient Care, the Greenwall Foundation, and the Harvard University Milton Fund. A recipient of a certificate of Excellence in Tutoring by the Academy at Harvard Medical School, Dr. Brown received a 2011 Radiological Society of North America (RSNA) Education Scholar Award, and a 2014 Boston Children’s Hospital Academy Medical Educator Award for Innovative Scholarship in Medical Education.
Jeff has more than 20 years’ experience applying human factors and systems-design principles to improve the safety, efficiency, and efficacy of health care. He has supported both quality improvement and research initiatives in civilian and military healthcare organizations and draws upon experience not only in health care, but from lessons learned in support of collaborative improvement in many safety-critical domains. These include border security, public safety, flight operations, regional electrical transmission, and naval operations, among others. For the past 6 years he has focused on the improvement of rural health and primary care. The first twenty years of Jeff’s career were in aviation, as a pilot and educator. He is a co-recipient of a 2002 John M. Eisenberg award for System Innovation. He earned his M.Ed. and B.S. degrees from the University of Maine.
Nora Kayton Bryant, PhD, ACRP® received her PhD in Molecular Physiology & Biophysics from Vanderbilt University in 2015. Her doctoral work defined direct effects of glucose toxicity on in vivo human beta cell function and transcription factor expression, in the laboratory of Al Powers, MD. In 2016, Dr. Bryant began a postdoctoral fellowship at the Joslin Diabetes Center, with Jason Gaglia, MD, working on clinical research protocols related to screening, prevention, and treatment of pediatric- and adult-onset type 1 diabetes. In 2018, Dr. Bryant became the Clinical Trials Manager for Dr. Gaglia’s entire clinical research portfolio, overseeing all regulatory, operational, and personnel aspects of investigator-initiated and industry-sponsored research. In addition, Dr. Bryant contributes to protocol design and authorship of manuscript and study-related documents. Some of her primary intellectual interests are the principles of trail design and trial conduct.
I am an executive coach and organizational consultant and certified in Coaching for Leadership & Professional Development by the Tavistock Institute of Human Relations. My practice builds on what I have learned, and the questions that made me curious, over a long career in leadership roles in important institutions in public service, the private sector, and for the past 20 years, academic medicine, healthcare and higher education. These roles include Chief Operating Officer and Interim Chief Executive Officer of the Beth Israel Deaconess Medical Center (a teaching hospital of Harvard Medical School), Executive Dean for Administration at Harvard Medical School and Deputy Provost for Administration at Harvard University, and Executive Vice President and Chief Operating Officer of a large private multi-specialty group medical practice. In addition to my private coaching and consulting practice, I am currently an Instructor in Health Policy and Management at the Harvard T.H. Chan School of Public Health, an Associate Faculty member of Ariadne Labs, and on the Advisory Board of the OpenNotes Initiative.
Ms. Calcasola serves as the Vice President of Quality and Safety for Hartford Healthcare an integrated healthcare system (4.0 billion revenue; > 30K employees) in Connecticut. Hartford Healthcare includes two tertiary-care teaching hospital, an acute-care community teaching hospital, an acute-care hospital and trauma center, three community hospitals, the state’s most extensive behavioral health network, a large multispecialty physician group, a regional home care system, an array of senior care services, a large physical therapy and rehabilitation network and an accountable care organization. In her current role, Ms. Calcasola leads quality and safety for the integrated health system. She is a nationally recognized leader and consultant in healthcare quality and patient safety. Ms. Calcasola speaks nationally on issues of healthcare quality, and is published in peer reviewed journals. Prior to her role at Hartford, Ms. Calcasola was Senior Director for Quality at Baystate Health in Massachusetts where she was instrumental in helping Baystate become a national leader in quality improvement. She has held a variety of positions over the last twenty-five years including cardiac staff nurse, educator, nurse manager, and clinical nurse specialist.
Ms. Calcasola received her BSN in nursing from Southern CT State University, New Haven, CT and her Masters of Science in Nursing at Yale University, School of Nursing, New Haven, CT. She is trained as an improvement advisor from the Institute of Healthcare Improvement.
Richard Cash’s research interests include scaling health programs. He conducted clinical trials of oral rehydration therapy on adults and pediatric cholera patients and interventions to scale up programs especially in diarrhea management. Dr. Cash has also developed programs to assist low and middle income countries’ scientists in honing their research skills and directs a program and workshops on research ethics.
Christy Cauley, MD, MPH is a faculty member in the Safe Surgery Program at Ariadne Labs. Her research focuses on patient centered outcomes and utilization of surgery in patients with serious illness. She helped develop and test a communication guide to improve surgical decision-making before emergency surgical interventions in patients with serious illness through funding from the Program for Cancer Outcomes Research Training Fellowship with the National Cancer Institute.
Dr. Cauley is a staff surgeon at Massachusetts General Hospital and Harvard Medical School in the Division of General Surgery with subspecialty training in Colon & Rectal Surgery. Christy received her B.S. from Purdue University, her M.D. at Indiana University, and her Masters in Public Health from Harvard University. She completed residency training in general surgery at Massachusetts General Hospital in Boston, MA followed by Colorectal Surgery fellowship training at Cleveland Clinic in Cleveland, OH.
Dr. Ann Celi cares for women after hypertensive pregnancy in the Brigham and Women’s Hospital Cardiometabolic Clinic in Maternal Fetal Medicine, a postpartum transition clinic that cares for and manages patients during the immediate postpartum period and transitions them to primary care. It opened its doors in October of 2011 and has cared for over 600 women creating new quality improvement efforts and an extensive educational outreach to interdisciplinary faculty and staff as well as trainees, medical students and nurses. Educated at Wellesley College, Harvard Medical School, and Harvard School of Public Health, she trained at Massachusetts General Hospital and Children’s Hospital in Internal Medicine and Pediatrics.
Often in collaboration with the Preeclampsia foundation, Dr. Celi has been actively engaged in education of patients and the general public through development of patient education materials and appearances on newspaper, radio, magazine, and social media appearances.
Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in vulnerable populations, and interventions on social determinants of health, such as food insecurity.
Alyna Chien’s area of research expertise is in the relationship between the structure of the health care system, the incentives and price information that doctors and patients face, and resulting health care quality and spending, particularly for vulnerable populations. Her work has shown that incentives can improve preventive and chronic disease care for adult and pediatric patients in mixed and low-income populations. Dr. Chien’s current projects include examining the structure of large health care organizations and the quality of pediatric health care they provide, understanding spending variation for “shoppable” conditions (childbirth, breast cancer and prostate cancer), understanding how medical providers respond to patient’s social needs, and describing care quality and spending among children with disabilities.
Kurt Christensen, PhD, is an Instructor in Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School whose research focuses on the medical, behavioral, and economic effects of integrating genomics into clinical and research settings. He has been an investigator on numerous high-profile NIH-funded trials of genomic information disclosure, including the REVEAL Study, which examined susceptibility testing for Alzheimer disease; the MedSeq Project which examined genome sequencing to adults; and the BabySeq Project, which examined exome sequencing of newborns. His published work has provided some of the earliest insight about the impact of population genomic screening for health systems, providers, and patients. Dr. Christensen is currently supported by an NIH Career Development focused on the cost-effectiveness of providing genetic screening to healthy adults. He is also a co-investigator on the PreEMPT Model, an NIH-funded effort to develop models to project the clinical and economic impact of newborn genomic screening. He also helps to lead a collaboration to examine the impact of providing genetic screening to patients of the Sanford Health System.
Isaac Chua received his BA in Music from Rice University and MD from The University of Texas Health Science Center – Houston, where he completed a scholarly concentration in the Medical Humanities. He completed his residency in Internal Medicine at Dartmouth Hitchcock Medical Center and a fellowship in Hospice and Palliative Medicine at Massachusetts General Hospital/Dana Farber Cancer Institute. He is currently a CRICO/Harvard Medical School Patient Safety and Quality Fellow at Dana Farber Cancer Institute, where he practices Palliative Care. His academic interests include improving teamwork, digital health application, and opioid safety within Palliative Care.
Dr. James Colbert is Senior Medical Director for Delivery System Innovation and Analytics at Blue Cross Blue Shield of Massachusetts (BCBSMA). He is the clinical leader for provider analytics and provider performance support within BCBSMA. His team is responsible for engaging with at-risk provider organizations to enable them to achieve success within their value-based contracts through managing TME and improving quality. He represents BCBSMA on the Board of Directors of the Healthcare Transformation Taskforce.
Prior to joining BCBSMA, he served as the VP of Population Health for Benevera Health, a joint venture between Harvard Pilgrim Health Care and four health delivery systems in New Hampshire. Other experiences include serving as Senior Medical Director for Population Health at Verisk Health and serving as a core faculty member of the Brookings Institution ACO Learning Network. He was the lead author of a 2014 Brookings Institution report entitled Adopting Accountable Care: An Implementation Guide for Physician Practices.
He received his bachelor’s degree from Harvard College and medical degree from Stanford University. He completed a primary care internal medicine residency at Brigham and Women’s Hospital as well as a fellowship in medical research and health policy at the New England Journal of Medicine. Dr. Colbert maintains an active clinical practice, and he holds faculty appointments at Brigham and Women’s Hospital, Ariadne Labs, and Harvard Medical School. In 2015 he was selected by MedTech Boston as one of 40 healthcare innovators under age 40. He lives in Jamaica Plain, MA with his wife and daughter.
Dr. Ebekozien is a national award-winning QI leader and a frequent keynote speaker at national conferences with over 15 years’ experience. He currently serves as the Vice President of Population Health and Quality Improvement at the T1D Exchange. In this role, he leads a team of experts in implementing population health strategies to improve the lives of people living with Type 1 diabetes by collaboratively working with over twelve national endocrinology centers.
Before joining the T1D Exchange, Dr. Ebekozien led the Office of Accreditation and Quality Improvement at Boston Public Health Commission (BPHC), in this role he works with a team to advance a culture of quality improvement, performance management, and other strategic initiatives for the city of Boston including implementing major population-based initiatives in partnership with Boston-based Hospitals. He led the city of Boston to achieve National Public Health Accreditation. He was awarded the 2018 City of Boston HHS Service Excellence Award and the 2019 NACCHO National Model Practice Award for creating an innovative QI program and impacting the lives of Boston residents. He also served as Faculty and Improvement Advisors for numerous national collaboratives focused on diabetes, HIV, asthma, workforce development, and health equity. In this role, he coaches and provides technical assistance to hospital networks, clinics, and community-based organizations. His previous collaborative experience include the Lead Faculty role for Morehouse School of Medicine National Diabetes Health Equity Collaborative, where he led organizations to reduce disparities in health outcomes for patients with type 2 diabetes.
Joyce K. Edmonds, Ph.D., M.P.H., RN, is an Associate Professor at Boston College, Connell School of Nursing.
She received an MPH from Oregon Health Sciences University and a PhD from Emory University. She has over fifteen years’ experience in nursing and public health practice and research focused on maternal health outcomes. Dr. Edmonds has a research appointment with the Munn Center for Nursing Research at Massachusetts General Hospital and is an Associate Faculty member at Ariadne Labs leading the Nursing Impact portfolio with the Delivery Decisions Initiative team. She is an active member of Association of Women’s Health Obstetric and Neonatal Nursing (AWHONN) and Chair-Elect of the American Public Health Association Nursing Section.
Edith Elliott is the co-founder and CEO of Noora Health, an organization that unleashes the power of patients and their family members by training them with skills to tremendously improve clinical outcomes, provide care and save lives. Edith believes that everyone, everywhere deserves the agency and human dignity associated with access to high quality healthcare. With a background in global health research, program implementation, design thinking and a passion for meeting users where they are, Edith recognizes that the best solutions are often the most simple and overlooked ones. Prior to Noora Health, Edith worked first at The Aspen Institute and then at Population Services International focusing on contractible disease prevention efforts. She has her BA in International Relations from Tufts University, her MA in International Policy and Global Health from Stanford University. Edith is an Ashoka Fellow, a Rainer Arnhold Fellow with the Mulago Foundation, a Draper Richards Kaplan Foundation Fellow, and a 2015 Echoing Green Fellow. In 2016, Noora Health was recognized by Fast Company as one of the 50 Most Innovative Companies in the World, and #2 in India.
Srinivas Emani is an Instructor in Medicine at the Laboratory for Computer Science at Massachusetts General Hospital and Associate Bioinformaticist in the Division of General Internal Medicine at Brigham and Women’s Hospital. His research interests are in the areas of patient engagement, patient portals, physician use of electronic health records, and ambulatory patient safety. In these areas, Dr. Emani is specifically interested in the application of innovation theories and social science theories to describe and explain individual and organizational perceptions, behaviors and processes. He is also interested in the role of evaluation frameworks such as the REAIM framework to assess and evaluate the generalizability of healthcare interventions.
Nic is chief science and technology officer at Ariadne Labs and oversees the computer-, data-, and implementation sciences teams. He is a cross-discipline specialist who has played key roles in building teams and pioneering innovation at technology and pharmaceutical companies. He has almost two decades of front line operating experience leading R&D teams, corporate strategy, innovation leadership, digital marketing/branding, business development, and strategic alliances.
Most recently, at the discretion of PerkinElmer’s CEO, Nic drove a new approach to innovation by establishing a new, semi-secret innovation lab and by leading the corporate cloud and IOT strategies. Prior to that, He was CEO and founder of Wingu, which was one of Google’s first venture investments in health technology (acquired by PerkinElmer in 2013). He also played early leadership and technical roles at Infinity Pharmaceuticals and TransForm pharmaceuticals. Nic began his career in the Human Genome Project as an engineer in the B.L.A.S.T. lab of Warren Gish.
Nic earned BS degrees in biology and psychology from the University of Rochester, an MS in Cell Biology, an MS in Computer Science, and an MBA in healthcare from Yale School of Management.
Shira H. Fischer is a physician policy researcher at the RAND Corporation focusing on health information technology research and policy. She has expertise in medicine, epidemiology, and technology, and experience in both qualitative and quantitative analyses with specific expertise in medication safety and electronic records, as well as an interest in data visualization. She recently led a contract for the Office of the Assistant Secretary of Health and Human Services for Planning and Evaluation examining the evidence for and evaluation of Extension for Community Healthcare Outcomes (ECHO) programs and another on opportunities to expand options for the entry-level health care workforce. Other recent work has included a project to integrate housing and medical data for patients with HIV and a large contract with CMS to standardize measurement in the post-acute care setting, focusing on medication reconciliation. She holds a BA in biochemical sciences from Harvard College; a PhD in Clinical and Population Health Research and an MD from the University of Massachusetts Medical School; and an MMSc in Clinical Informatics from Harvard Medical School. She also holds academic appointments at Harvard Medical School and Brigham and Women’s Hospital.
David Frank, MD, PhD is the Medical Director for Patient Safety at the Dana-Farber Cancer Institute. Dr. Frank oversees all patient level safety and quality issues, infection control, and patient complaints concerning the quality of care. He also oversees the continual monitoring of the professional practice of all physicians, nurse practitioners (NPs), and physician assistants (PAs). In addition, Dr. Frank chairs the Institute’s Pharmacy and Therapeutics Committee, and spearheads efforts in optimizing medication safety. In all of these roles, he not only helps lead the response to safety events that occur, but he also helps analyze “near misses” and conducts proactive risk assessments to develop systems-level solutions to prevent errors before they can occur.
Dr. Frank, who attended Stuyvesant High School in New York, received his undergraduate degree at MIT, and his MD and PhD from Yale. He was subsequently an intern, resident, and chief resident in internal medicine at Yale, after which he trained in medical oncology at the Dana-Farber Cancer Institute. In addition to his safety roles, Dr. Frank directly cares for patients with hematologic malignancies, runs a laboratory developing novel targeted signal transduction inhibitors, and teaches at Harvard Medical School.
Erik Fromme, MD, MCR, Faculty, Serious Illness Care Program.
Ashveena Gajeelee is a public policy specialist with strong experience in public finance and global health. She is an affiliate of the Global Access in Action (GAiA) Fellow at the Berkman Center for Internet & Society at Harvard University, where she supports GAiA’s action-oriented research on global public health challenges faced by the world’s most vulnerable populations.
Ashveena is currently working with African Ministries of Finance to improve budget planning and execution and reforms. Over the coming years, she will be looking at how governments can improve the efficiency of the health systems through a more strategic finance mechanism.
Prior to her work at GAiA, Ashveena was a teaching fellow for the Adaptive Leadership course at the Harvard Kennedy School. She has worked in several governmental ministries in her home country of Mauritius, including Agriculture, Prime Minister’s Office, and Environment. After several years in government, she joined the Financial Services Commission, where she was the Head of Policy and International Affairs. Following the financial crisis, Ashveena was intensely active in working with Southern African Development Community countries to implement international norms in the financial services sector and ensuring compliance to fight money laundering and financing of terrorism. As a Fulbright Humphrey Fellow, she worked at the Federal Reserve Bank of Boston to research the best practice of community development outreach and financial literacy. She was most recently, the advisor to the Minister of Finance and Economic Development. She has a strong research interest in pandemic preparedness and the use of artificial intelligence in healthcare.
Ashveena holds an MPA from Ecole Nationale d’Administration (ENA), France, and a dual master from the Harvard Kennedy School of Government (MPA) and the Graduate Institute of Geneva (International Affairs).
Shaan Gandhi is a Principal at Northpond Ventures, where he oversees Northpond’s creation, origination, sourcing, diligence and monitoring efforts in therapeutics as well as leads Northpond’s Boston office. Prior to joining Northpond Ventures, he was a Principal at the Longwood Fund, where he created and invested in life sciences companies, including Pyxis Oncology, a cancer immunotherapy company focused on novel modulators of the tumor microenvironment, which he co-founded and served as President. Previously, he was an attending hospitalist at the Massachusetts General Hospital, where he also did his residency in internal medicine. He holds an M.D. from Harvard Medical School, an M.B.A. from Harvard Business School, where he was a Baker Scholar, a D.Phil. in medical oncology from the University of Oxford, where he was a Rhodes Scholar, and a B.S. with honors in biochemistry from Case Western Reserve University. He is Vice President of the Suffolk District Medical Society, the professional medical society of Boston, and a trustee of the Boston Medical Library.
Ishani Ganguli MD MPH is an Assistant Professor at Harvard Medical School and Brigham & Women’s Hospital (BWH) Division of General Internal Medicine and a practicing primary care physician at BWH Advanced Primary Care Associates. She is a health services and policy researcher studying the value of ambulatory care – specifically, primary care payment and delivery, the care of patients with medical and social complexity, and cascades following low-value medical tests. Ishani received her AB, MD, and MPH from Harvard University. She trained in Internal Medicine/Primary Care and completed fellowship in health policy and management at Massachusetts General Hospital (MGH). During fellowship, she led hospital-wide initiatives on patient education and patient-reported outcome measures and practiced primary care at the MGH Ambulatory Practice of the Future. Ishani is also a journalist who has written about science and health care for The Boston Globe, Reuters, The New York Times, and The Washington Post, among other publications.
Atul Gawande, MD, MPH, is a surgeon, writer, and public health leader. He is a surgeon at Brigham and Women’s Hospital and a professor at Harvard Medical School and the Harvard T.H. Chan School of Public Health. He is the founder and chair of Ariadne Labs, a joint center for health systems innovation, and of Lifebox, a nonprofit organization making surgery safer globally. He is also chairman of Haven, where he was CEO from 2018 to 2020.
Atul has also been staff writer for The New Yorker magazine since 1998 and written four New York Times best selling books: Complications, Better, The Checklist Manifesto, and Being Mortal: Medicine and What Matters in the End. He is the winner of two National Magazine Awards, AcademyHealth’s Impact Award for highest research impact on healthcare, a MacArthur Fellowship, and the Lewis Thomas Award for writing about science.
Dr. Esteban Gershanik is a Medicine Hospitalist at Brigham and Women’s Hospital and Dana Farber Cancer Institute in Boston and Pediatric Hospitalist at Children’s Hospital of New Orleans. During the COVID-19 pandemic, he recently served as Chief Medical Officer for the Medical Monitoring Station at the Convention Center in New Orleans and Medical Director for the first federally designated drive through testing site with their health department. He also continues to serve on the Brigham Health COVID 19 Equity, Diversity, and Community Health Response Team.
Previously, Esteban has served as CIO, Health Informatics Director, and Medical Consultant for the Louisiana Department of Health. He led and advanced state efforts on their clinical and public health policies, HIT Roadmap, data and electronic health records (EHR) utilization, emergency preparedness, and opioid data surveillance for which he and his team were nationally recognized with federally funded awards from the CDC and Department of Justice.
Esteban was an inaugural member of the master in medical science degree in clinical informatics from Harvard Medical School as a National Library of Medicine Fellow, received his medical and master in public health in health systems management degree from Tulane University, and received his undergraduate degree from Emory University. He is a Fellow in the American Academy of Pediatrics and Society of Hospital Medicine, has served as faculty at MIT, Tulane Schools of Medicine and Public Health, LSU Schools of Medicine and Public Health, and currently a member at Ariadne labs and Part-Time Instructor at Harvard Medical School.
Roya Ghazinouri PT, DPT, MS, is Instructor in Orthopedic Surgery at Harvard Medical School and the Director of Operations and Strategy at the Center for Healthcare Delivery Sciences, an academic research organization at Brigham and Women’s Hospital (BWH), dedicated to improving health care by identifying, designing, rigorously evaluating, and reporting transformational solutions to engage patients and providers in care delivery
Prior to her role at the Center, Roya led numerous quality improvement and process improvement initiatives at Memorial Sloan Kettering Cancer Center and Brigham and Women’s Hospital. Her interest and passion for improving health care quality stems from her clinical background and experience as a physical therapist and her desire to promote seamless, multidisciplinary and evidence-based care for patients. Over the past 20 years, she has designed and led numerous programs to reduce unnecessary variation in practice and improve collaboration and communication among teams. A dedicated clinician and educator, Roya has co-authored numerous publications in physical therapy, orthopedic outcomes research, quality improvement and health services research.
Dr. Gitomer is the Director of the Brigham Health Primary Care Center of Excellence (COE). In this role he oversees approximately 200 primary care providers within sixteen locations across the Brigham catchment area. Until COVID the COE was focusing on creating a value-based primary care platform within a large academic medical center.
Prior to the current role, Dr. Gitomer was the President and Chief Quality Officer of the Emory Healthcare Network (EHN). The EHN is a clinically integrated network owned by Emory Healthcare. At the time, it included five hospitals and 2,000 physicians of which 450 were in independent practice. In that role he provided clinical leadership in payer negotiations, worked with administrative partners to create the governance, management and operational infrastructure for the network, led the development of the high-risk care coordination program, and led the development of the data and analytics infrastructure for oversight of the clinical operations.
Prior to his involvement with the EHN Dr. Gitomer was the inaugural Chief Quality Officer at Emory University Hospital Midtown (EUHM). In this role he oversaw the development of the quality improvement infrastructure at EUHM and was on the senior leadership team developing the quality infrastructure for Emory Healthcare. During his tenure, EUHM rose from the 4th quintile to achieve top 10% performance in quality and safety across US academic medical centers.
Prior to these roles Dr. Gitomer served numerous leadership roles within Primary Care for The Emory Clinic with the last being Clinical Chief for Primary Care.
As Chief Scientific Officer, Emeritus, and Senior Fellow at the Institute for Healthcare Improvement, Dr. Goldmann focuses on deepening the credibility of improvement science by forging relationships with key scientific, academic, and health services research organizations. He has experience across the translational research continuum (bench science, epidemiology, clinical trials, and implementation research). He advances the rigor of IHI’s results-oriented work by deploying sound project design and program evaluation methods appropriate for the context in which improvement initiatives are conducted. Dr. Goldmann advocates for integration of improvement science with both HIT/technology and epidemiology to accelerate progress towards vibrant and effective learning health systems, clinical decision support, and population health and equity. Dr. Goldmann explores new ways to teach, bringing promising innovations to in-person and distance-learning. He is lead faculty for a IHI/HarvardX Massive Open Online Course (MOOC) on Practical Improvement Science, which has been expanded to an on-line credit course at the Harvard TH Chan School of Public Health. He is Co-director for the Harvard-Wide Pediatric Health Services Research Fellowship Program he founded (funded since 1994 via NRSA T32 Training Grants). He leads a Harvard College General Education course that explores how infectious diseases lead to social injustice and influence history, art, and literature.
Dr. Goldmann has a keen interest in helping clinical teams integrate rigorous quality improvement into their routine work, while mitigating clinician burnout and liberating the intrinsic motivation that clinician bring to health care. He is particularly devoted catalyzing sustainable improvement in under-resources settings globally and in engaging medical trainees in quality improvement. Dr. Goldmann has served as Chair of the AHRQ National Advisory Council and the Board of AcademyHealth, and he is Vice-Chair of the Advisory Committee of the Institute for Medicaid Innovation. He also serves on a number of advisory committees and boards, including the National Quality Forum’s Primary Care and Chronic Illness Standing Committee. He is Professor of Pediatrics, Harvard Medical School and Professor of Immunology and Infectious Diseases, and Epidemiology, Harvard T.H. Chan School of Public Health.
Eric Goralnick, MD, MS serves as Medical Director, Emergency Preparedness and Access Center, Brigham Health. He is responsible for system wide efforts to prepare, mitigate, respond, and recover from disasters in addition to coordination of all outside hospital transfers to the Brigham Health system. He is an Associate Professor of Emergency Medicine at Harvard Medical School. He is the faculty lead for the Harvard Medical School Civilian Military Collaborative , the Brigham and Women’s Center For Surgery and Public Health emergency medicine initiatives, an IHI faculty member and a US veteran.
Tamryn Gray, RN, PhD, MPH is a Health Services Researcher in Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute and Brigham and Women’s Hospital and Instructor in Medicine at Harvard Medical School. Her research focuses on improving care delivery and outcomes for patients with serious illness and their caregivers across the care continuum. She is particularly interested in developing solutions that spur health system and policy changes to leverage patient-family centered care, palliative care, and care transitions as innovation points to improve health outcomes. With clinical expertise in hematology and oncology, she also holds a role in the DFCI Division of Stem Cell Transplantation and Cellular Therapies engaged in research, innovation, and quality improvement efforts. Dr. Gray holds bachelor’s degree and master’s degrees from the University of North Carolina at Chapel Hill, an MPH from Harvard, and a PhD from Johns Hopkins University.
Robert C. Green, MD, MPH is a physician-scientist and Professor of Medicine (Genetics) at Harvard Medical School who directs the Genomes2People Research Program at Brigham and Women’s Hospital and the Broad Institute. Dr. Green is an internationally recognized leader in conducting research and developing policies to accelerate the implementation of genomic and precision medicine. He led the first experimental trials disclosing genetic risk for common complex disease and the first prospective studies to evaluate outcomes in direct-to-consumer genetic testing services. His work established the safety and feasibility of disclosing genetic risk information, assessed the impact of whole genome sequencing in primary care, created the concept of aggregate penetrance of genomic variants in a prospective population cohort and demonstrated the clinical utility and cost-effectiveness of genomic sequencing in healthy adults (the MedSeq Project), newborns (the BabySeq Project) and the active duty military (the MilSeq Project). Dr. Green recently established the Brigham Preventive Genomics Clinic in Boston, and co-founded a tech-enabled telegenomics specialty practice, Genome Medical, that is now operating in all 50 US states. He is leading policy development for returning genomic information to research participants within the Global Alliance for Genomics and Health, the Verily-Google Baseline Project and US Precision Medicine Initiative.
Susan Haas is co-PI for Ariadne Labs’ CRICO-funded work focused on reducing health care system expansion risks to patient safety. She oversees the planning and execution of the expansion risks work to design and test tools to be used prior to (elucidating the risks) and after affiliation ( prioritizing and mitigating the risks). Current work focuses on: 1) Understanding the risks to patients when physicians are sent to practice part-time in an unfamiliar affiliated hospital and developing risk mitigation tools; and 2) Understanding the mechanisms of risk surrounding decision and implementation to transfer patients between affiliated hospitals.
Tahir is a Hospitalist at Brigham and Women’s Hospital and Instructor in Medicine at Harvard Medical School. In addition to his clinical role, he focuses on creating sustainable community development projects and improving access to care in rural areas across the globe. Tahir serves as the Director of the MSI Foundation, a non-profit organization which provides free education and vocational training to battered women in India. Tahir has a background in medical innovation and has led multiple biomedical projects to improve bedside, cardiac, orthopedic procedures; he holds a patent for a cardiac surgery device. His research work focuses on racial and gender health disparities as well as cardiac outcomes in patients with viral illnesses such as HIV and Zika. He brings a unique perspective to the organization with his experience in global health, biomedical innovation & policy work and aims to continue his work on health delivery and equity to improve the practice of medicine.
Joaquim Havens MD, is investigating the burden of emergency general surgery in the United States. He has developed and tested the use of an emergency general surgery checklist and intra-operative huddle under a grant from CRICO. In collaboration with Johnson and Johnson he has helped develop a Device Briefing Tool which has been pilot tested in Thailand and is currently being tested throughout Singapore.
Alex Haynes’ research focuses on improving surgical care delivery through measurement and implementation of quality improvement initiatives. His work bridges environments as diverse as acute care hospitals in South Carolina, where he has been involved in the Safe Surgery 2015 collaborative, to ambulatory surgery centers across the country, as well as hospitals and health systems around the globe. He recently led efforts to report the outcomes of the Safe Surgery 2015 program, finding a significant reduction in postoperative mortality from inpatient surgery paralleling changes in teamwork and communication in the operating rooms. In collaboration with colleagues from the Harvard Business School, Dr. Haynes is running a study to investigate the links between hospital management practices and quality of clinical care, including the ability to implement large-scale quality improvement projects, funded with a research grant from the Rx Foundation. He has also recently launched a collaboration with Dr. JP Onnela of the Harvard T.H. Chan School of Public Health to harness smartphone technology to better understand how surgery affects patient centered outcomes, including physical, emotional, and social well-being. This work will result in methods to measure and assess surgical care, as well as tools for counseling patients and monitoring outcomes outside of the clinical environment.
Dan Henderson trained in internal medicine at Columbia University/New York-Presbyterian Hospital, and holds degrees from the Harvard School of Public Health, the University of Connecticut School of Medicine, and Trinity College.
As a primary care physician, Dr. Henderson’s focus is a big-picture approach to the wellness of the patients he serves, particularly those with complex medical conditions. His approach emphasizes heart disease prevention, stress management, healthy lifestyle care, medical weight loss treatment, men’s health, and affirming care for patients of all sexual and gender identities. Dr. Henderson is committed to achieving the best possible care for his patients, and is passionately involved in driving the health system innovations needed to accomplish this. Previously, Dr. Henderson served as the Resident Patient Safety and Quality Officer for Columbia University Medical Center, and the first Health Justice Fellow of the American Medical Student Association (AMSA). Currently, he directs the Clinical Process Improvement Leadership Program (CPIP) for MGH and Partners Healthcare and participates in a variety of system change programs.
Natalie Henrich is the Associate Director of Science and Technology at Ariadne Labs and Technical Lead of the Improvement and Implementation Science Team. In her current role, she works with Ariadne’s project teams to use scientific methods to strengthen the design and measurement of their innovative intervention projects as they progress from initial discovery of solutions through wide-scale spread. Natalie also leads Ariadne Lab’s Context Assessment for Successful Implementation project, which is focused on assessing implementation context and integrating results into implementation strategies, at scale. Throughout her career she has researched and evaluated health issues and programs focusing on effectiveness, acceptability and feasibility, ethicality, and stakeholder needs. Much of her work has dealt with early stages of implementation addressing factors such as barriers and facilitators to acceptance and use, attitudes towards novel innovations and practices, and how communications can be better aligned with stakeholder needs to increase buy-in and enable informed decision-making. Natalie is the co-author of a book, “Why Humans Cooperate.”
David Hepner is a co-investigator on the Ariadne Labs Agency for Health Care Research and Quality Crisis Checklist project. He also serves on the Emergency Manuals Implementation Collaborative Steering Committee with Ariadne Labs.
Lindsay Hunt, MEd, is the Director of Systems Transformation with the Harvard Medical School Center for Primary Care. In this role, Lindsay is responsible for the overall management of the Center’s Systems Transformation portfolio, including the HRSA-funded Advancing Teams in Community Health Program, the Primary Care Improvement Network and leadership programs such as the Medical Director Leadership Institute. Most recently she has been leading efforts to support Primary Care practices across Massachusetts and nationally to navigate the many challenges related to the COVID-19 pandemic. Prior to joining the Center for Primary Care Lindsay worked for nine years at the Institute for Healthcare Improvement (IHI) where she led a variety of internal and external improvement projects including the development of IHI’s first internal leadership development program. She also helped to launch The Conversation Project, a national campaign to promote end-of-life conversations. Lindsay holds a Masters of Education with a focus on Adult and Organizational Learning from Northeastern University and a Bachelors of Arts from Cornell University.
Joe Jacobson served as Chief Quality Officer at Dana-Farber Cancer Institute between 2011 and 2020. In that role, he oversaw a large department responsible for the quality and safety of care on the academic campus and an expanding network. Between 2003 and 2011, he served as the Chair of Medicine at North Shore Medical Center. He is trained in Medical Oncology and Hematology, received a mid-career Masters degree in Epidemiology, and completed additional training at the Intermountain Healthcare Institute for Healthcare Delivery Research. He has practiced extensively in both academic and community settings. For over two decades, he has helped develop and implement a series of national, regional and local quality measurement and improvement programs, largely focused on cancer care. He is an Associate Professor of Medicine at Harvard Medical School and a Fellow of the American Society of Clinical Oncology.
I am a clinician investigator at Beth Israel Deaconess Medical Center and an Assistant Professor at Harvard Medical School. I see patients through my primary care clinic part-time, while the bulk of my work involves executing clinical trials focused on disease prevention. I spent over 10 years in training at Johns Hopkins University, completing my medical degree, a doctorate in cardiovascular disease epidemiology, internal medicine training through the Osler residency program, and a general internal medicine research fellowship. I have published over 100 papers (over half first-authored) from a diverse range of data sources. In addition, I have participated in the primary publication of 7 distinct clinical trials focused on nutrition and lifestyle interventions to improve clinical outcomes. I am currently the principal investigator on two NIH grants and am a national expert in blood pressure variability with recent co-authored a Scientific Statement by NHLBI on blood pressure measurement. I am passionate about the role of nutrition to optimize blood pressure and promote healthy aging in older adults. A critical factor of my work focuses on access to healthy foods by vulnerable populations in the U.S. My trial aspirations center on testing scalable interventions in nutrition that can address the soaring international hypertension epidemic.
Dr. Ingrid Katz, MD, MHS is the Associate Faculty Director of the Harvard Global Health Institute, and an Assistant Professor in Medicine at Harvard Medical School. She serves as an Associate Physician in the Department of Medicine at Brigham and Women’s Hospital and is a research scientist at the Center for Global Health at Massachusetts General Hospital. Her research over the past decade has focused on the social determinants of health-seeking behavior among people living with HIV in sub-Saharan Africa, with the goal of developing sustainable, socio-behavioral interventions aimed at improving care for the most underserved. She is trained in Infectious Diseases and received her MD from the University of California at San Francisco and trained in Internal Medicine at Brigham and Women’s Hospital, and in Infectious Diseases at Beth Israel Deaconess Medical Center. She completed a fellowship in Global Women’s Health at Brigham and Women’s Hospital and has been on staff there since 2009. She has been consistently funded as a Principal Investigator through the National Institutes of Health since 2012 and has served as an Editorial Fellow and a National Correspondent for the New England Journal of Medicine.
Ravi Kavasery, MD, is Medical Director of Quality and Population Health for AltaMed Health Services — the largest federally qualified health center in the United States, serving the communities of Los Angeles. An experienced physician leader in primary care delivery systems, Dr. Kavasery’s responsibilities include leading a team dedicated to health system improvement, patient safety, population health analytics, and ambulatory care redesign. Dr. Kavasery is a board certified internist and practices primary care at AltaMed’s Southgate clinic, which is also the site of AltaMed’s Family Medicine residency training program. Prior to joining AltaMed, Dr. Kavasery was Medical Director of Clinical Development and Performance for Iora Health, an innovative primary care group renowned for its leadership and transformation in reducing hospitalizations, saving healthcare costs, and improving the patient experience. As one of the earliest physicians to join Iora Health, Dr. Kavasery led a multi-disciplinary team in the development and implementation of the organization’s expansion across seven states while garnering national recognition for its primary care model.
Dr. Kavasery is an associate faculty member with the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School as well as an associate faculty member with Ariadne Labs, a joint-center for health systems innovation founded by Dr. Atul Gawande between Brigham and Women’s Hospital and the Harvard School of Public Health. Dr. Kavasery is a published author in peer review and non-peer review publications and an invited guest lecturer and presenter throughout the country. During his clinical training, Dr. Kavasery has worked with Partners in Health in Rwanda and Malawi. He has also done clinical work in Uganda, the Navajo Nation, South Korea, Malaysia, and Argentina. Ravi has received multiple teaching awards from the Harvard Medical School Academy for Teaching and Learning. Prior to medical school he was named a Henry Luce Foundation Scholar.
Perry is a Boston Consulting Group (BCG) Senior Partner, Fellow Emeritus and a member of the Global Leadership Team for BCG’s People and Organization Practice. He founded and led BCG’s Change Management topic for 11 years, and now leads BCG’s collaboration with the Project Management Institute (PMI). He joined The Boston Consulting Group in 1988 as an associate in our Auckland office. After spending extensive time working in the BCG Asia system Perry returned to BCG Auckland for a six-year term leading that office before transferring to Chicago in 2006. He has deep expertise in change management, enterprise program management, business strategy and transformation. He has worked extensively in the North American, Asia Pacific and European/Middle East Regions.
Perry has a BSc in mathematics and a ME in mechanical engineering from the University of Auckland, and is a graduate of the Harvard Business School Program for Management Development. Additionally, he is a Chartered Professional Engineer, a Fellow of the Institution of Engineering and Technology and a Fellow of the Institution of Mechanical Engineers. Prior to joining BCG Perry worked as a manufacturing engineer. His publications include several important articles with the Project Management Institute and Harvard Business Review including “Strategic Initiative Management – The PMO Imperative”, “Executive Sponsor Engagement”, “The Hard Side Of Change Management” and “Lead Change Successfully”. He is a contributing author to HBR’s “Ten Must reads on Change Management” series.
I am currently a postdoctoral research fellow affiliated with the Department of Surgery at Harvard Medical School, and working with Dr. Marco A. Zenati, Chief of Cardiothoracic Surgery in the Division of Cardiac Surgery at the VA Boston Healthcare System in West Roxbury. My research is ultimately focused on enhancing patient safety by introducing and evaluating cognitive aids aimed at improving surgical teams’ cognitive and non-technical performance. My previous work as a doctoral student in the Department of Translational Biology, Medicine, and Health at Virginia Tech focused on physiological indicators of cognitive workload, and discerning the relationship between these indicators and 1) self-perceived levels of stress and cognitive workload and 2) task performance. I investigated the utility of using biofeedback and coping instructions as a cognitive aid for providers. The primary project in our multi-institutional research group at the VA focuses on an adaptive intra-operative procedural checklist designed to provide guidance to the cardiac surgery team during cardiac surgery operations including aortic valve replacement and coronary artery bypass graft surgery. We are interested in the team dynamics, including physiological measures of cognitive workload, communication patterns, situational awareness, and patient outcomes. Future work I’m interested in involves incorporating my multiple interests with an eye towards using physiological data alongside cognitive aid checklists to contribute to cardiac surgery team members’ awareness of and coping with workload changes.
Ramin Khorasani’s current research focuses on use of innovative health IT tools, quality improvement methodologies and change management strategies to improve quality, safety and efficiency of health care care. He published a paper with Dr. Atul Gawande titled “Use of Public Data to Target Variation in Providers’ Use of CT and MR Imaging among Medicare Beneficiaries.” He also presented a talk at an Ariadne Labs’ Innovation meeting titled “Health IT enabled evidence-based practice: Gains, Gaps, and Opportunities.”
Dr. Bharti Khurana is an Assistant Professor in the Department of Radiology at Harvard Medical School and a practicing emergency and musculoskeletal radiologist at the Brigham and Women’s Hospital. She is also the Program Director for Emergency Radiology Fellowship and Clinical Director for Emergency Musculoskeletal Radiology at BWH.
Dr. Khurana is passionate about trauma imaging, particularly optimizing MRI protocols in an emergent setting, providing meaningful imaging interpretations by incorporating a checklist approach and developing machine learning algorithms for injury detection. She believes in harnessing the power of artificial intelligence for radiologists to move beyond clinical diagnosis, collaborate with multidisciplinary care teams, improve overall health outcomes and be an agent of social change. Currently, she is working on establishing the role of radiologists in proactively identifying Intimate Partner Violence (IPV) victims. Additionally, as an associate faculty at Ariadne labs, Dr. Khurana is designing a Clinical Decision Support System (CDSS) and an automated alert generation for IPV detection, for use by the wider community.
Dr. Kuhn is Medical Director for Critical Care at Cambridge Health Alliance and a HMS Clinical Instructor, based in the Division of Pulmonary and Critical Care, Department of Medicine. He also provides attending coverage for the Division of Infectious Diseases, and serves as the co-director of the Thoracic Mass Program at CHA. Dr. Kuhn completed an undergraduate degree at Brown University, and an MD at the Harvard-MIT Health Sciences and Technology Program. He went on to complete Fellowships in Infectious Disease (Case Western/University Hospitals of Cleveland), Critical Care (University of Washington), and Pulmonary Medicine (Partners/MGH). He also conducted basic science research in fungal pathogenesis. His current interests include ICU Quality Improvement, rationalization of resource utilization, care at end-of-life, and modernization of critical care practices in under-resourced settings.
I am an Associate Professor of Neurology at Harvard Medical School and a practicing stroke neurologist at Beth Israel Deaconess Medical Center. A primary focus of my efforts has been to develop coherent management strategies for stroke care that encompasses different phases of stroke recovery. Whereas significant advances have been made in management of acute ischemic strokes, evidence based care beyond this period remain poorly developed. Specifically the impact of stroke complications and issues with post-stroke disability remain inadequately studied and measures to mitigate their effects are poorly developed. I have established cross disciplinary collaborations towards this end and have received grant funding from the NIH, CIMIT and private foundation to support these endeavors. I also serve as an investigator for the NINDS Stroke Trial Network, whose goal is to promote collaboration across institutions and identify promising stroke treatments that can be transitioned into phase 3 trials. I am actively involved in teaching and supervising residents, students and fellows and have an avid interest in improving their education generally and experiential learning more specifically. I have been a recipient of teaching awards and honored with invitations to speak on wide ranging topics in clinical and stroke neurology at local, national and international venues.
Joshua Lakin serves as the clinical lead for the Serious Illness Care Program at Brigham & Women’s Hospital, both in primary care and general inpatient medicine settings. His recent research focuses on the implementation of the program in primary care. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families.
Daniela Lamas served as the Clinical Lead for the Spaulding Rehabilitation Hospital pilot project testing the acceptability and feasibility of the use of the Serious Illness Care Conversation Guide with chronically critically ill patients and their surrogates. She plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. She also works on clinical and research projects aiming to better understand and improve outcomes for patients who have survived critical illness.
Kimberlyn Leary’s research interests include delineating the components of effective leadership and the interpersonal exchanges that promote change and collaborative decision-making. She also studies the factors that improve health and life outcomes for women and girls, including women and girls of color.
Anne CC Lee, MD, MPH is an Assistant Professor of Pediatrics at Harvard Medical School and practices clinical newborn medicine at the Brigham and Women’s Hospital. She is the Director of Global Newborn Health Research in the Department of Pediatric Newborn Medicine at the BWH. Her primary research focus is the design, implementation, and evaluation of feasible, low-cost and high impact public health interventions to reduce the major causes of perinatal mortality in low-middle income country (LMIC) settings.
Dr. Lisa Soleymani Lehmann is a primary care physician and bioethicist. She serves as Chief Medical Officer for the VA New England Healthcare System which is a multi-state integrated healthcare system comprised of 8 medical centers and 41 community-based outpatient clinics that serves over 260,000 Veterans. Prior to serving VA New England, Lisa was Executive Director of the VA National Center for Ethics in Health Care and Director of Bioethics at Brigham and Women’s Hospital. Lisa is Associate Professor of Medicine at Harvard Medical School (HMS) and Associate Professor of Health Policy and Management at the Harvard T. H. Chan School of Public Health.
Lisa is a graduate of Cornell University, where she was a College Scholar studying philosophy, chemistry and near eastern studies. She received her MD and PhD in philosophy from Johns Hopkins University, completed her residency in internal medicine at Johns Hopkins Hospital, and was a fellow in the HMS Fellowship in General Medicine and Primary Care and the HMS Fellowship in Medical Ethics. She received a Master of Science in clinical epidemiology from the Harvard School of Public Health.
Her research focuses on how to improve care for patients and families at the end of life, the relationship between moral courage, speaking up and patient safety, how to responsibly integrate genomics into clinical medicine, and the intersection of ethics and health policy. Dr. Lehmann was Chair of the Society of General Internal Medicine Ethics Committee, Chair of the Framingham Heart Study Ethics Advisory Board, a member of the American College of Physicians Ethics, Professionalism and Human Rights Committee, and Chair of the HMS Scholars in Medicine Medical Humanities Advisory Committee.
Jeff Levin-Scherz is a senior director and the co-leader of North American Health Management Practice at Willis Towers Watson, where he helps large employers develop, implement and evaluate their health management strategy, including care management programs, incentive programs, and technology programs.
Jeff leads intellectual capital development for Willis Towers Watson in the Health Management space. Jeff has written and spoken widely on health care reform, especially around the adoption of disruptive innovation, and the use of behavioral economics to drive performance in the health care delivery system and behavior among employees and in the general population. His work has been published in JAMA, the Journal of General Internal Medicine, and the Harvard Business Review.
Jeff has a broad range of experience in health care delivery and finance. He served as a physician executive leader of provider organizations including a large independent practice association, an integrated delivery network, a multispecialty group practice, and a venture-funded technology enabled national primary care practice. He also served for seven years as a vice president of a top-ranked regional health plan. Jeff has been a participant in technical expert panels convened by the Centers for Medicare and Medicaid Services, the Institute of Medicine and the Urban Institute.
Jeff is an Assistant Professor at the Harvard TH Chan School of Public Health, where he teaches courses on provider payment and managing health care costs. He has given guest lectures frequently, including at Columbia University’s Mailman School of Public Health and The Wharton School at the University of Pennsylvania. Jeff has an MD from the Boston University School of Medicine, and received his MBA from Columbia Business School.
David Levine is a practicing general internist and investigator at Brigham & Women’s Hospital and Harvard Medical School. His research focuses on digital health, care redesign, and the quality of delivered health care. He believes fast iterative design grounded in robust research methodology yields results. Among other projects, his team runs a home hospital randomized controlled trial to bring acute care to acutely ill adults as a substitute for traditional hospitalization. They are deploying remote wireless monitoring, predictive analytics, and high-touch care in the home.
Stuart Lipsitz is a biostatistician at Ariadne Labs, and is heavily involved in virtually all programs and research at Ariadne Labs. His specialty is advanced statistical methods, and he has developed new techniques that are widely used in studies with missing data, repeated measures studies, and complex sample surveys.
Saranya Loehrer, MD, MPH, Head of Innovation, Institute for Healthcare Improvement (IHI), leads a team of curious and creative researchers responsible for exploring seemingly intractable impediments to health and health care improvement and developing actionable theories and tools that can be tested in collaboration with partners worldwide. In addition, she supports select efforts of the IHI Leadership Alliance, a group of 50+ leading US health care executives working courageously and collaboratively to deliver on the full promise of the Triple Aim. Prior to joining IHI, Saranya worked for Physicians for Human Rights, leading global and domestic grassroots advocacy efforts to create more just and scientifically sound HIV/AIDS policies. She received her MD from Loyola University Chicago Stritch School of Medicine, where she was an Albert Schweitzer Fellow, and her MPH from the Harvard School of Public Health, where she was a Zuckerman Fellow.
Dr. Lubitz received her undergraduate and medical degrees from the University of Michigan. During her general surgery residency at Cornell, she spent two dedicated years studying the genetic basis of thyroid cancer. Following completion of her endocrine surgery fellowship at MGH in 2010, she obtained an MPH at the Harvard School of Public Health, during which time her commitment to health services research, and in particular the application of comparative effectiveness to surgical disease, was solidified. She has had excellent mentored research opportunities, including the Program in Cancer Outcomes Research Training fellowship (2011-2013) and an NCI K07 award (2014-2019). She is now an Associate Professor of Surgery at the Harvard Medical School in the Division of Surgical Oncology, a member of the MGH Endocrine Surgery Unit, and a senior scientist at the Massachusetts General Hospital Institute for Technology Assessment. She holds a number of national leadership positions including the program committee chair and executive council member of the American Association of Endocrine Surgeons and the Recorder of the Association of Academic Surgery.
Her overarching research mission has been to improve the health and well-being of patients with benign and malignant endocrine-related diseases. She is the PI of an R-37 (R01-type merit award) award to examine the potential impact of new diagnostic technologies and personalized management strategies in patients with thyroid cancer using mathematical disease simulation modeling and an American Cancer Society Research Scholar Award to develop a thyroid-cancer specific quality of life index.
Ernest Mandel serves as the Clinical Lead for the Dana-Farber Cancer Institute-Brigham & Women’s Faulkner Hospital project studying the adaptability and feasibility of integrating the Serious Illness Care Program into a busy dialysis center. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for clinicians to conduct discussions about end-of-life goals and preferences with seriously ill patients and their families.
Kenneth Mandl works at the intersection of population and individual health with a focus on biomedical informatics. He received a Presidential Early Career Award for Scientists and Engineers for pioneering real time biosurveillance, tracking infections, and detecting outbreaks with diverse data. Dr. Mandl developed SMART, a widely adopted, highly influential approach, to enabling substitutable iPhone-like apps that run universally on health IT systems. He most recently presented his work in a talk entitled “Building the App Store for Public Health: A Perfect Storm” at an Ariadne Labs’ Innovation meeting.
Lindsay A. Martin, MSPH, is a healthcare improvement and innovation leader dedicated to system design, improvement, and innovation. She founded I-Squared Consulting Group and works with government entities, healthcare systems, and community organizations to advance the role of quality and safety within health systems and across populations. Ms. Martin is an Instructor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health where she teaches Methods and Tools for Quality Improvement. Ms. Martin is Faculty for the Institute for Healthcare Improvement where she focuses on improvement, innovation, and the role of employers in healthcare delivery. In addition, Ms. Martin is on the Board of Trustees for New England Donor Services (which coordinates organ and tissue donation in the six New England states and Bermuda). Prior to her current roles, Ms. Martin was the Executive Director of Innovation at IHI where she oversaw IHI’s Innovation process, working to find new solutions to difficult problems in health care and bringing those solutions into prototype testing. Ms. Martin received a Master of Public Health from the Harvard T.H. Chan School of Public Health and a Bachelor of Science in Biology from Georgetown University.
Duncan Maru collaborates on grants and implementation research methodologies with Ariadne staff and faculty. He is the co-founder, chief strategy officer, and a board member of Possible, a non-profit health care company that delivers high-quality, affordable health care in rural Nepal on a public-private partnership model. Possible’s staff of approximately 250 cares for over 130,000 patients per year. Dr. Maru oversees the vision and execution of Possible’s work in government partnerships, impact evaluation, and implementation science. Possible has deployed an open-source electronic medical record (EMR) that integrates care from community health care workers to clinics and hospitals. Through this EMR, Possible aims to implement quality improvement practices, perform surveillance, and conduct rapid, low-cost randomized evaluations of delivery innovations.
Dr. Marcus M. McKinney is a Psychotherapist (LPC CT) in Northeast Connecticut at Day Kimball Healthcare. His 35-year career includes serving as Regional Vice President & Chief Health Equity Officer for Trinity Health Of New England, a five hospital system in Hartford, CT. He is Co-Founder of the Curtis D. Robinson Center for Health Equity at Saint Francis, and served Saint Francis Hospital since 1984 as an educator, minister, clinical director and supervisor in academic and community settings. He maintains a faculty appointment at the University of Connecticut School of Medicine as an Assistant Professor in Psychiatry, studied under Dr. James Hillman, and has published in the areas of pastoral psychotherapy, depth psychology and community health.
A graduate of the University of Maryland at Baltimore County, Southwestern Baptist Theological Seminary, and Andover Newton, Marcus is a fellow in the American Association of Pastoral Counselors and often presents nationally regarding research and practice in psychology and community health issues. He is a graduate and faculty affiliate of the Massachusetts General Hospital Disparities Solutions Program under the direction of Joseph Betancourt and a recipient of the Healthcare Heroes Award of the Connecticut Hospital Association for his work in Health Disparities.
In 2013 Dr. McKinney joined Ariadne Labs Team as an Affiliate Faculty member. Dr. McKinney’s work in addressing health disparities has been recognized by the Association of American Medical Colleges (AAMC) and the Alliance of Independent Academic Medical Centers (AIAMC). Marcus and Valerie reside in Pomfret, Connecticut.
Kate Miller supports quantitative research designs, statistical analyses, and mixed-methods approaches across Ariadne’s research portfolio, including the Better Birth, Serious Illness, and Primary Health Care initiatives. Dr. Miller’s interests include innovative research designs, implementation science, quality of care, and women’s health.
Namita Seth Mohta, MD, is a physician executive with expertise in health care delivery transformation. As the Clinical Editor for NEJM Catalyst, she is part of the founding leadership team and has responsibility for content strategy and quality. She has been part of the founding Population Health and ACO leadership teams at both Partners Health Care and the New England Quality Care Alliance (Tufts Medical Center), both in Boston. Her responsibilities have included designing and implementing ACO strategies for Medicare, Medicaid, and Commercial populations, with a focus on scaling tailored clinical interventions, integrating analytics and measurement, and leading change management and team-based care with providers. Dr. Mohta also has industry experience as a management consultant with the Boston Consulting Group. She often consults with start-ups (currently with PatientPing, GNS Healthcare, and Day Health Strategies) to provide strategic and technical expertise and leadership. Dr. Mohta practices internal medicine at the Brigham and Women’s Hospital and is faculty at The Center for Healthcare Delivery Sciences and at Harvard Medical School. She completed her Internal Medicine and Primary Care residency training at the Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.
Namita Seth Mohta, MD, is a physician executive with expertise in health care delivery transformation. Dr. Mohta is faculty at Ariadne Labs, a health system innovation lab at Brigham & Women’s Hospital and the T.H. Chan School of Public Health, where she is part of the Serious Illness Care Program (SICP). She supports the scale and spread of initiatives that improve outcomes for patients with serious illness.
Rose Molina, MD, MPH is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She works as a board-certified obstetrician-gynecologist at The Dimock Center and Beth Israel Deaconess Medical Center. She completed the Global Women’s Health Fellowship at Brigham and Women’s Hospital and obtained a Master of Public Health in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health. Dr. Molina works as Associate Faculty at Ariadne Labs to design, test and spread solutions to ensure that every woman receives appropriate, safe, and respectful care during pregnancy and childbirth. Her current research focuses on improving shared decision-making in obstetric care. Her current advocacy work seeks to advance access to language-concordant and culturally-humble health care for all, especially undocumented immigrants in the United States. Dr. Molina also serves as a Women’s Health Advisor for Partners In Health in Chiapas, Mexico, an organization she has worked with since 2008.
George Molina, MD, MPH is a Surgical Oncologist in the Department of Surgery at Brigham and Women’s Hospital. He is an Associate Faculty in the Safe Surgery Safe Systems Program at Ariadne Labs. His research in the lab centers on using health systems innovations to improve safety, quality, and equity in surgical care. As part of his training in General Surgery at Massachusetts General Hospital, he completed a two-year post-graduate research fellowship at Ariadne Labs. During this time he worked on projects in health systems innovation and research, global surgery modeling, surgical safety culture in inpatient and ambulatory settings, and impact of a surgical safety checklist program.
Gordon Moore is Professor of Population Medicine at HMS. He trained at the Massachusetts General Hospital. In the late 1960’s he joined the founding group of Harvard Community Health Plan, the country’s first academically sponsored HMO, where he eventually became medical director and chief operating officer. While there, he built its first health center in Cambridge, Massachusetts and practiced as a primary care internist there for 40 years. In his academic work he designed and started the New Pathway, a new curriculum at Harvard that has become a worldwide model for medical education. He later became program director of the Robert Wood Johnson initiative to train graduate doctors and nurses in systems thinking and practice improvement. His most special interests are the design, organization, and management of health care delivery systems. He is lead author of Choice Matters: How Healthcare Consumers Make Decisions (and Why Managers and Clinicians Should Care), published by Oxford Press in 2018.
Matthew Mossanen is a urologist at Brigham & Women’s Hospital and Massachusetts General Hospital. Dr. Mossanen received his MD from the David Geffen School of Medicine at the University of California Los Angeles and completed his residency in urology at the University of Washington Medical Center. His research interests involve the quality of, access to, and delivery of cancer care. He received a Partners in Health Policy Grant to support a project that attempts to create a cost-effective, easily scalable program to help cancer patients, especially the elderly and frail, prepare for morbid operations. He supports the use of checklists in the pre-operative period to help cancer patients, caregivers, and providers by focusing on high-yield tasks. Dr. Mossanen is interested in improving the quality of care provided to cancer patients in the US and abroad.
Dr. Ruvandhi Nathavitharana is a TB researcher and attending physician in Infectious Diseases at Beth Israel Deaconess Medical Center and Harvard Medical School. She graduated from Imperial College Medical School London with honors and obtained her MPH from Harvard School of Public Health as a UK Kennedy Scholar. Dr. Nathavitharana completed internal medicine residency at NYU/Bellevue Hospital and trained in Infectious Diseases at Beth Israel Deaconess Medical Center.
TB has re-emerged as the leading cause of death due to an infectious disease globally. TB transmission from patients with unsuspected disease is the major driver of TB incidence. Dr. Nathavitharana’s research interests center around using implementation science to optimize diagnostic strategies to decrease TB transmission. Dr. Nathavitharana is also the Vice Chair of TB Proof, an advocacy organization that seeks to destigmatize TB and mobilize national and global resources to end TB.
Dr. Larissa Nekhlyudov is an Associate Professor in the Department of Medicine at Harvard Medical School and is a practicing internist at the Brigham & Women’s Hospital in Boston, Massachusetts. She is also Clinical Director, Internal Medicine for Cancer Survivors at the Dana-Farber Cancer Institute where she offers clinical consultations for long term survivors of childhood and adult cancers. Dr. Nekhlyudov is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care. Over the past decade, Dr. Nekhlyudov has been at the forefront of the field of cancer survivorship, including the development of survivorship care policies and clinical guidelines, educational programs and research. She is an active member of the Society of General Internal Medicine, the American Society of Clinical Oncology, the National Comprehensive Cancer Network and served on committees at the National Academies of Sciences, Engineering and Medicine (formerly the Institute of Medicine).
JP Onnela’s research focuses on statistical analysis and mathematical and computational modeling of social and biological networks and their connection to human health. His other main research area is digital phenotyping. Prior to joining the Department of Biostatistics at the Harvard T.H. Chan School of Public Health in November 2011, he was a Postdoctoral Research Fellow at Harvard Medical School, a Fulbright Visiting Scholar at the Harvard Kennedy School, and a Junior Research Fellow at Oxford University. He obtained his doctorate at the Helsinki University of Technology in 2006. He received National Institute of Health Director’s New Innovator Award in 2013.
I am a clinical investigator and clinically active as an associate physician in the Emergency Department (ED) and a home hospital physician in the Department of Medicine at Brigham and Women’s Hospital / Brigham and Women’s Faulkner Hospital. I earned my Masters of Public Health at Harvard and completed my research fellowship in the Department of Psychosocial Oncology and Palliative Care at Dana Farber Cancer Institute.
As a physician trained in Internal Medicine and Emergency Medicine, I see a gap in quality of care for older adults with serious, life-limiting illness. Most such patients are reluctant to discuss their goals for medical care despite their progressive illness. The opportunity to have in-depth conversations about values and preferences (abbreviated, the “conversation”) with any physician is scarce, and many such patients present to the ED without any advance directives. This not only complicates the care in the ED, but it is a missed opportunity to facilitate this important conversation. I am passionate about aligning the care to patient’s values and preferences at the end of life. My current research focuses on identifying older adults who would benefit from these conversations and empowering them to formulate their goals for medical care in the ED. By facilitating high-quality conversations to understand patient’s values and preferences, I will achieve this goal, so that every patient with serious illness will receive the type of care that he/she deserves.
Erika A. Pabo, MD, MBA is an experienced physician executive, healthcare strategist and social entrepreneur with deep expertise leading primary care practice operations and growth, piloting and scaling innovative population health management programs, and building and implementing tech-enabled solutions to achieve the quadruple aim.
Dr. Pabo joined Humana in the fall of 2018 to serve as Chief Health Officer for Edge working to create a fundamentally new experience and better outcomes for seniors who need it most. In this role she oversees strategy and operations across member service, care management, utilization management, clinical pharmacy, clinical quality/STARS, social determinants of health, and supplemental virtual/in-home care delivery including behavioral health, primary care extensivist and IHWA for Edge’s members.
She continues to serve as Faculty at Harvard Medical School and Associate Faculty at Ariadne Labs and to practice primary care at Brigham and Women’s Hospital Advanced Primary Care, South Huntington a Level III Patient Centered Medical Home in Jamaica Plain. She speaks regularly at national healthcare conferences on virtual care delivery, primary care redesign, social determinants of health and population health. She has published work in venues such as Health Affairs, JAMA Internal Medicine, Clinical Cardiology and Harvard Business School Publishing.
Prior to joining Humana, she served as the Medical Director for Population Health and the Associate Director for Brigham and Women’s Hospital Primary Care Center of Excellence. In these two leadership roles, she oversaw the population health management portfolio for 210,000 patients as well as overseeing primary care patient growth, operational improvement, and care delivery innovation in areas ranging from behavioral health and substance use disorders, to risk coding and documentation, to physician compensation across 20 practices with 195 physicians, 45 advanced practice clinicians and 400 other associates.
Prior to her work at BWH, she worked at Twine Health (acquired by Fitbit), Harvard Medical School Center for Primary Care, The Institute for Healthcare Improvement, and the Global Health Delivery Project. Erika has also provided consulting services to health care delivery and health care technology companies, incubators and investors.
Erika earned a BA in History of Medicine from Yale College, a medical degree from Harvard Medical School and an MBA from Harvard Business School. She completed her residency in Internal Medicine in both the Primary Care and Management and Leadership tracks at Brigham and Women’s Hospital in Boston and is ABIM board certified in Internal Medicine
Joanna (Jo) Paladino is a palliative care physician, implementation specialist, educator, and researcher. She currently serves as the Associate Director of Implementation for the Serious Illness Care Program at Ariadne Labs. The serious illness care team has developed an evidence-based program that includes communication tools, clinician training, and systems-changes. Jo’s research in a randomized controlled trial in oncology demonstrates that the program leads to more, earlier, and better conversations about patients’ values and goals in serious illness, as well as significant improvements in patient well-being. To translate this research into measurable and lasting improvements in communication and care on a broad scale, Jo is the clinical lead for a project that expands this model to health systems throughout the country. She is also one of a small group of faculty educators and has trained hundreds of clinicians to have compassionate and effective serious illness conversations with their patients. Jo earned her MD from Weill Medical College of Cornell University and is board certified in internal medicine and palliative care. She lives with her husband Savan in Boston, Massachusetts.
Dr. Parikh is a medical oncologist with a focus on gastrointestinal malignancies at the Massachusetts General Hospital and faculty at Harvard Medical School. She has a robust clinical practice and is also involved with drug development and translational research, including work with liquid biopsies and the PI of a first of its kind national trial, funded by Stand up 2 Cancer using liquid biopsies in Stage III colon cancer. Despite academically focused on translational research, she has had a long standing commitment to efforts in enhancing the patient experience across all patient populations and particularly for enhancing access to care for otherwise marginalized patient populations. One such effort has been the launching of a training program called POETIC, for sub-Saharan African oncologists to enhance their local training. Trainees come to Boston for an intensive program designed to give them tangible clinical and research skills they can use locally but also to foster connections that will enhance their ability to care for patients in low- and middle-income countries. She also enjoys teaching and mentoring and runs the training program for GI oncology for the Dana Farber/Mass General Cancer Center Oncology fellows at MGH.
Gareth Parry, PhD, Senior Scientist at IHI, leads the internal evaluation and dissemination system within IHI. Based on 30 years of experience in the quality and health services research field, he provides scientific leadership in several IHI programs and chairs the annual IHI Scientific Symposium. He regularly consults, teaches and presents on measurement and evaluation methods nationally and internationally. He serves as Clinical Assistant Professor at Harvard Medical School. Prior to joining IHI, Dr. Parry was an Improvement Advisor for the National Initiative for Children’s Healthcare Quality and Director of Quality Measurement and Analysis at Children’s Hospital Boston. In the UK, he was Research Director and Reader (US equivalent Associate/Full Professor) in Health Services Research at the University of Sheffield, evaluating health services delivery and developing and applying risk-adjustment methods in neonatal, pediatric and adult critical care, and Postgraduate Degree Director of the Health Services Research program, designing course curriculum and mentoring students and faculty. He has over 75 peer reviewed publications.
I love helping people and organizations thrive by conducting rigorous person-centered clinical research. My research focuses on implementing clinically relevant qualitative and quantitative metrics to measure the impact of social and behavioral health interventions at scale as well as establishing use cases for how, when (and if) to leverage artificial intelligence and machine learning algorithms to guide decision-making in clinical settings.
I am a research epidemiologist by training and have been involved in applied public health for over 15 years. My work as a first author and contributing researcher has been presented at national conferences and webinars, and published in journals such as PLoS Medicine, Journal of Managed Care Pharmacy, Vaccine, PLoS Currents: Influenza, and American Journal of Public Health. My methodological training includes Harvard Medical School, Massachusetts Department of Public Health, University of Massachusetts Medical School, Boston University School of Public Health. I have a PhD in Clinical and Population Health Research from the University of Massachusetts Medical School, an MPH in Global Health/Epidemiology from Boston University School of Public Health, and a BA in French and Chemistry from Colgate University in Hamilton, NY.
Richard Platt, MD, MSc is Professor and Chair of the Harvard Medical School Department of Population Medicine at the Harvard Pilgrim Health Care Institute. He is principal investigator of the FDA’s Sentinel System that studies of the safety and effectiveness of marketed medical products. Dr. Platt is also co-principal investigator of the coordinating center of PCORI’s Patient Centered Outcomes Research Institute, leads the NIH Health Care Systems Research Collaboratory’s Distributed Research Network, and is co-principal of a CDC Prevention Epicenter. He is a member of the Association of American Medical Colleges’ Advisory Panel on Research. He is a former chair of the FDA’s Drug Safety and Risk Management Advisory Committee, and co-chair of the Board of Scientific Counselors of the Centers for Disease Control and Prevention’s (CDC) Center for Infectious Diseases.
Deb Polzin-Rosenberg, RN, MArch is a nurse and architectural designer. She began her career training to be a midwife, but the sterile labor and delivery room, chaotic nursing stations and incessant beeping and chiming of the hospital environment left her deeply dissatisfied with the typical U.S. birth experience. She practiced as a registered nurse (RN) for many years in women’s health until she decided to tackle birth as a design problem. She earned a Master’s of Architecture (MArch) from the Rhode Island School of Design (RISD) in 2015, where she was awarded a Graduate Studies Travel Grant to research the design of birth spaces in the UK and The Netherlands. In 2016, she worked with a team from MASS Design Group and Ariadne Labs to conduct research on the impact of design on clinical care in childbirth. Funded by a generous grant from the Robert Wood Johnson Foundation, this study compared twelve diverse types of birthing facilities across the U.S. and explored ways that design affects clinical processes, decision-making and outcomes. Their work was published in HERD: Health Environments Research and Design Journal, the Journal of Midwifery and Women’s Health, featured in the Review of Systems podcast and recently profiled in FastCompany. She lived and worked in Rwanda, as a designer with MASS Design Group, on several birth-oriented architectural projects in East Africa, including innovative maternity units for two district hospitals in Kigali and Munini and a Postnatal Unit for a rural community hospital outside Lilongwe, Malawi.
In her current role as Health Design Strategist with GA Collaborative, a Kigali-based architecture and design firm, she is pursuing research to inform design strategies to improve the safety and experience of birth among women living in rural Rwanda. She is also applying for a U.S. Fulbright Scholarship to study the design of maternity spaces in Sweden. She has studied and designed for healthcare in both the Global South and Global North and found that despite the enormous disparity in resources, there are lessons to be learned from both.
Jason Pradarelli, MD, MS is the Medical Director at the Academy for Surgical Coaching, a not-for-profit organization dedicated to establishing a national network for surgeons to implement coaching for performance improvement. He is also a general surgery resident at Brigham and Women’s Hospital and a former safe surgery fellow at Ariadne Labs. He is passionate about finding better ways for practicing surgeons to learn new procedures and skills and to improve their performance after graduating from residency/fellowship. Jason graduated from The Ohio State University for college and the University of Michigan for medical school. He obtained a Master of Science in Clinical Research while at Michigan and arrived in Boston in 2016 for general surgery residency.
Audrey Provenzano MD, MPH is an internist who specializes in the care of vulnerable populations. After completing her training in internal medicine and primary care at Brigham and Women’s hospital and the Kraft Fellowship in Community Health Leadership, she joined the faculty at MGH and HMS, where she provides clinical care, supervises trainees, works in quality improvement, writes, and produces a podcast about primary care called Review of Systems with the Harvard Center for Primary Care. She is also on the faculty of the Center for Primary Advancing Teams program which provides technical assistance and training in QI principles in Community Health Centers in the Boston area. Her quality improvement portfolio over the last few years has included developing and implementing a novel fall risk assessment screening and intervention program, improving care after discharge from hospitals, and developing and implementing structured treatment programming for patients with opioid use disorders in the primary care setting.
Yuri Quintana focuses on developing innovative technologies that empower communities of professionals and consumers to collaborate on a worldwide basis. He is currently the Director for Global Health Informatics in the Division of Clinical Informatics, Beth Israel Deaconess Medical Center and Assistant Professor in Medicine at Harvard Medical School. Yuri does research and teaching on topics of global health information systems, global e-health applications, clinical informatics, consumer health informatics, mobile health systems, online learning systems, and serious games for health and wellness.
Ruma Rajbhandari, MD, MPH is an Associate Scientist in the Division of Global Health Equity and an Instructor at Harvard Medical School. Her global health focus is on health systems strengthening, human resources for health, quality of care and maternal and child health. Dr. Rajbhandari also serves as the Research Advisor for the Nick Simons Institute, a Nepal-based non-governmental organization whose mission is to innovate solutions in rural healthcare –through training and hospital support– and to advocate for their scale up with the government of Nepal. Her clinical practice is in the Division of Gastroenterology, Hepatology and Endoscopy where her primary interest is viral hepatitis, particularly hepatitis B, and general gastroenterology.
Dr. Rajbhandari is a graduate of the Doris and Howard Hiatt Global Health Equity Internal Medicine Residency Program at Brigham and Women’s Hospital. During residency, she divided her time between Boston and rural clinics and small district hospitals in the impoverished areas of Lesotho, Rwanda and Nepal. While in Nepal, she worked with the Nick Simons Institute and Possible. Currently, she also serves on Possible’s Advisory Board.
Dr. Rajbhandari earned her bachelor’s degree from Yale University, her MD from Harvard Medical School and her MPH from Harvard School of Public Health. She has also completed a fellowship in Gastroenterology and Hepatology at Massachusetts General Hospital, and earned a diploma in Tropical Medicine and Hygiene from the Gorgas Memorial Institute in Lima, Peru.
Cherie Lynn Ramirez is a faculty member in the Chemistry and Physics Department at Simmons University, where she teaches courses in biochemistry and public health. She earned her PhD in genetics at Harvard studying site-specific nucleases and their applications in genome engineering. She completed her post-doctoral training at the Harvard T. H. Chan School of Public Health and has held appointments at the Harvard Global Health Institute and the Global Health Education and Learning Incubator at Harvard University, where she led faculty, graduate, and post-doctoral professional development activities related to global health teaching across Harvard University. Among her current research projects are studying institutional mechanisms that promote healthy workplaces and improving access to medicines as a Collaborator of Global Access in Action (GAiA), a project of the Berkman Klein Center for Internet & Society at Harvard University.
Christine Ritchie, MD, MSPH is Professor of Medicine and the Ken Minaker Chair of Geriatric Medicine at Massachusetts General Hospital (MGH) in Boston, Massachusetts. She is a board-certified geriatrician and palliative care physician and conducts research focused on optimizing quality of life for those with chronic serious illness and multimorbidity. She has provided geriatrics and palliative care to functionally impaired, seriously ill patients with multiple co-occurring conditions and those with dementia for the past two and a half decades.
Her research focuses on patients with complex serious illness and multimorbidity and involves the assessment of patient and caregiver outcomes related to symptoms physical, cognitive and social function among older adults in multiple settings. As a clinician investigator, she has experience in informatics, mixed methods research, clinical trials and implementation science. She has conducted a number of trials in vulnerable populations and assisted with the development and implementation of complex care coordination interventions for persons with serious illness. Dr. Ritchie serves as MPI of the National Institute for Nursing Research-funded Palliative Care Research Cooperative (PCRC) and directs the PCRC Investigator Development Center. She is co-founder and co-director of the Home-based Primary Care and Palliative Care Research Consortium with co-investigator Dr. Bruce Leff.
She serves as Director of Research for the Division of Palliative Care and Geriatric Medicine at Massachusetts General Hospital and of the MGH Center for Aging and Serious Illness Research.
Born and raised in Denver, Colorado, Shapir Rosenberg, MD graduated magna cum laude and Phi Beta Kappa from the University of Pennsylvania with a concentration in Philosophy. He completed a residency in Psychiatry at the University of Maryland Medical Center where he was inducted into the Gold Humanism Honor Society. He is currently a fellow in Hospice and Palliative Medicine at the University of South Florida in Tampa. He is the Editor-in-Chief of the American Journal of Psychiatry Residents’ Journal. He has a passion for end-of-life care, teaching, and the medical humanities.
Raffaella Sadun, an Ariadne Labs SPARK grantee, is focusing her research at Ariadne on the relationship between economics of productivity, management, and organizational change in hospitals. She collaborates with Dr. Alex Haynes, Associate Director of the Safe Surgery Program, on several projects developing methods to measure the quality of health system management, its effect on patient outcomes, and the design and implementation of management improvement programs.
Lipika Samal is a co-SPARK grantee of Ariadne Labs with Associate Faculty Dr. Joseph Jacobson. Their work is focused on improving cancer care delivery. Dr. Samal also researches the use of the electronic health record to improve chronic disease management and care coordination. She is funded by the National Institutes of Health under a research project grant to design and evaluate a clinical decision support system for chronic kidney disease.
Justin Sanders serves as the clinical lead for a project focusing on disparities in care of the seriously ill, as well as a project focusing on the implementation of the Serious Illness Care Program internationally. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. He was recognized in 2016 as an emerging leader in the field of Palliative Care with a Sojourns Scholar Leadership Award from the Cambia Health Foundation.
Dr. Gordon Schiff is a general internist and Associate Director of Brigham and Women’s Center for Patient Safety Research and Practice, Associate Professor of Medicine at Harvard Medical School, and Quality and Safety Director for the Harvard Medical School Center for Primary Care.
Before coming to Harvard in 2007, he worked for 3 decades at Chicago’s Cook County Hospital where he was professor of Medicine at Rush Medical School and PI of the AHRQ Developmental Center for Patient Safety Research Project focusing on diagnostic errors. He headed the AHRQ PROMISES (Proactive Reduction in Outpatient Malpractice: Improving Safety Efficiency and Satisfaction) malpractice and patient safety improvement project. He was an invited expert and reviewer for the 2015 National Academy of Medicine (IOM) Report: Improving Diagnosis in Health Care. He was recently awarded a grant from the Gordon and Betty More Foundation to create a multifaceted research learning network (PRIDE (Primary-care Research in Diagnosis Errors) to study and improve diagnosis in a number of areas.
Dr. Schiff was PI on a recent FDA CPOE Medication Safety project and White paper, and led the AHRQ-Brigham medication safety HIT CERT CEDAR (Calling for Earlier Detection of Adverse Reactions) Project and a new AHRQ HIT Safety project to enhance electronic prescribing safety by incorporating the drug indication into the prescription order. He is PI on a grant to study issues related to professional-patient boundaries and breakdowns in physician patient relationships funded by the Arnold P. Gold Foundation for Medical Humanism. He chairs the editorial board of Medical Care, and is on editorial board of the Journal Public Health Policy and BMJ Quality and Safety in Healthcare.
Ryan is a physician, and currently the Director of Policy for Accountable Care at MassHealth, and serves on the Secretary’s Massachusetts COVID19 Response Command Center. Ryan’s background is in organizational leadership and healthcare policy. He is the former COO of Possible, Nepal’s first public-private partnership, value-based healthcare organization, and he continues his work in Nepal as a senior technical advisor. Ryan has advised multiple governmental health systems globally as a technical adviser to the World Bank and Global Financing Facility, and previously worked in the opioid use disorder field focusing on medication assisted treatment care models. Ryan is a practicing internal medicine and pediatrics physician at MGH’s Chelsea Health Center and faculty at Brigham & Women’s Hospital and Harvard Medical School.
Dan Schwarz, MD MPH is the Director of Primary Health Care at Ariadne Labs. Dan brings over a decade of global experience in healthcare delivery.
Prior to joining Ariadne Labs, Dan served as the Executive Director, and then Chief Medical Officer for Possible (www.possiblehealth.org), in which role he helped to build and lead an innovative public private partnership for healthcare delivery with the Nepali Ministry of Health. This work now spans multiple districts throughout Nepal, providing both facility- and community-based services to over 500,000 people. Now at Ariadne, Dan continues to serve as a Strategic Adviser to the organization and the Nepali government. Before his work in Nepal, Dan has also worked for Partners In Health (www.pih.org) in multiple countries, and several other non-governmental organizations throughout sub-Saharan Africa and southern Asia. Dan serves as an adviser to the World Health Organization in their Primary Healthcare Measurement Initiative, and an adviser to the Lancet Commission on Noncommunicable Diseases and Poverty.
Katherine Semrau, PhD, MPH, is director of the BetterBirth Program at Ariadne Labs. As Program Director, Dr. Semrau oversees the research and execution of the BetterBirth Program which aims to improve the quality of care, minimize complications, and end the preventable deaths of women and newborns through effective implementation of evidence-based, scalable solutions at the frontline of care. Katherine is an Assistant Professor of Medicine at Harvard Medical School and an Associate Epidemiologist at the Brigham and Women’s Hospital in the Division of Global Health Equity.
Neel Shah directs the Delivery Decisions Initiative (DDI) at Ariadne Labs, which aims to ensure every person can start or grow their family with dignity. Dr. Shah’s team is currently implementing the Team Birth Project, a trial involving hundreds of clinicians and tens of thousands of families across the United States that aims to deliver childbirth care is safe, supportive and empowering for every mother, every time. DDI has ongoing collaborations with global stakeholders in maternal health, including health professionals, family advocates, payers, policymakers, employers and others.
Mahek A. Shah leads and directs the Value Measurement for Health Care projects at Harvard Business School. As Senior Researcher and Senior Project Director, he designs and implements time-driven activity-based costing (TDABC) globally to help providers, governments, and employers understand real and actual costs of care delivery. He focuses on maximizing value for all stakeholders through reorganization of care delivery, disruptive innovation, and improving the health care experience for all. Dr. Shah is also Associate Faculty at Ariadne Labs and serves on the Board of Operation Airway. He has spent his career at the intersection of health, business, and technology.
Dr. Shah is the co-author of several Harvard Business School (HBS) case studies. His research has been published in the Journal of the American Medical Association (JAMA), World Health Organization (WHO), the Wall Street Journal, New York Times, and Forbes. Shah delivered a TEDx talk at Harvard: Bringing Patient-centered Design to Healthcare. Shah speaks globally on the future of health care delivery, value-based care, innovative delivery models, and the business of healthcare.
Prior to medicine, Dr. Shah worked on Wall Street as an investment banker at Citigroup. Dr. Shah can be found on twitter @Mahek_MD
Amie Shao is a Principal with MASS Design Group, where she oversees research focusing on health infrastructure planning, design, and evaluation. Blending human-centered design practices with evidence-based research, Amie has collaborated with Ariadne Labs and the Robert Wood Foundation to investigate the Impact of Design on Clinical Care in Childbirth, coordinated the production of National Health Infrastructure Standards for the Liberian Ministry of Health, and developed infection control design resources for USAID. Her work is aimed at engaging and empowering stakeholders in the design process; supporting and substantiating the impact of design on health, social, and environmental outcomes; and translating research into guidelines that can be used to advocate for policy change. Amie received her Master of Architecture and a Certificate in Urban Policy & Planning from Princeton University.
Dr. Silobrcic is currently Executive Advisor to Innovaccer, Inc., where he was previously Vice President and Executive Director, Innovaccer Academy, heading the company’s efforts around its industry-leading platform for training programs and resources in transformative, value-based care. He is also Course Director and Adjunct Faculty in the Health Policy and Management Department of the Harvard T.H. Chan School of Public Health, advisor to an investment enterprise, and Entrepreneur-in-Residence (EiR) at the Harvard University Innovation Labs (iLab).
Formerly, he was Senior/Executive Strategy and Business Advisor to several healthcare ventures, and Chief Strategy Officer for a healthcare IT enterprise. Prior to this, he was Executive Director of Healthbox, a leading platform for healthcare innovation acceleration, driving actionable collaboration between technology entrepreneurs, the healthcare industry and investors, in building a global community dedicated to driving change in healthcare. Previously, Dr. Silobrcic was Associate Partner, Strategy and Senior Medical Scientist, Care Delivery Systems, at IBM Research, where he used his deep healthcare industry expertise to help lead a market-focused research agenda that created high value solutions for IBM, providing transformative value to clients and health systems, globally. This included work on innovative IBM’s Health and Wellness solutions for Smarter Cities and Communities, and on advanced healthcare analytics and decision support solutions, including the applications of IBM’s breakthrough Watson (cognitive computing/AI) technology. Formerly, he was also an Associate Partner in strategy, operations and innovation/transformation practices of major global professional services (consulting) firms: Deloitte Consulting, IBM Global Business Services and Accenture.
Prior to and between those roles, he was a senior executive with or advisor to various healthcare ventures, including healthcare technology (e-health/digital, IT, device) startups. As leader, he has spearheaded organizations/teams, various programs, projects and intellectual capital development efforts, as well as leadership development and assessment initiatives. He is an experienced speaker, panelist, facilitator, judge at many and varied healthcare industry events.
Arabella Simpkin is the Associate Director of the Center for Educational Innovation and Scholarship at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. She recently became the inaugural Manager of Innovation Strategy at Harvard Macy Institute. Arabella trained in adult medicine and paediatrics in the UK, and holds Membership to the Royal College of Paediatrics and Child Health.
Arabella’s research focuses on medical decision-making, with particular emphasis on how best to acknowledge and communicate uncertainty. She is committed to designing and researching innovative approaches to the teaching of medicine particularly in diagnostic reasoning, resilience, and embracing uncertainty.
Arabella earned an MA in Physiological Sciences and a medical degree (BMBCh) from Lincoln College at Oxford University, and an MMSc in Medical Education from Harvard Medical School. She is currently enrolled in a DPhil program in the Department of Pharmacology at Oxford University.
Anna D. Sinaiko, PhD is an Assistant Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. She has expertise in health economics and health policy, with a particular focus on consumer decision-making and how information and financial incentives alter consumer behavior in health care settings. Specific empirical projects include an examination of consumer response to tiered physician networks, of the impact of a web-based price transparency tool, and of choice of health insurance plans in Medicare and in private insurance.
Sara J. Singer, M.B.A., Ph.D., is a Professor of Medicine at the Stanford University School of Medicine, Professor by courtesy at the Stanford Graduate School of Business, and Adjunct Professor of Health Care Management and Policy at the Harvard T. H. Chan School of Public Health. At Stanford, she is affiliated faculty with the Freeman Spogli Institute for International Studies, Center for Health Policy/Center for Primary Care and Outcomes Research, Center for Innovation in Global Health, and Clinical Excellent Research Center. From 2012-2017, she served as Implementation Research Director for the Safe Surgery 2015 initiative. Her research in the field of health care management and policy focuses on how organizational leadership and culture impact efforts to implement health delivery innovations, integrate patient care, mitigate social determinants that undermine health; and improve safety and reliability of health care organizations. A key feature of this research is the development of survey instruments that measure provider and patient perspectives on key interpersonal and organizational factors, enabling benchmarking, rapid and reliable feedback about the effectiveness and comparative effectiveness of delivery system innovations, and broader dissemination of more successful interventions. Dr. Singer has published more than 150 peer-reviewed articles on healthcare management, health policy, and health system reform. She has received numerous awards for publications and teaching; she also received the 2013 Avedis Donabedian Healthcare Quality Award from the American Public Health Association and shared the 2013 Lewis W. Blackman Patient Safety Champion Award Recipient, awarded to the Safe Surgery: South Carolina program.
A Board-certified medical geneticist, Dr. Skotko is the Emma Campbell Endowed Chair on Down Syndrome at Massachusetts General Hospital. As the Director of the hospital’s Down Syndrome Program, he has dedicated his professional energies toward children with cognitive and development disabilities. He co-authored the national award-winning books, Common Threads: Celebrating Life with Down Syndrome and Fasten Your Seatbelt: A Crash Course on Down Syndrome for Brothers and Sisters. He is a graduate of Duke University, Harvard Medical School, and Harvard Kennedy School, and he is currently an Associate Professor at Harvard Medical School. Dr. Skotko is a leader on clinical and translational research about Down syndrome. He has been featured in The Wall Street Journal, The New York Times, The Washington Post, The L.A. Times, NPR’s “On Point,” and ABC’s “Good Morning America.” Dr. Skotko has a sister with Down syndrome and serves on the Honorary Board of Directors for the Massachusetts Down Syndrome Congress.
Douglas S. Smink, MD, MPH is the Chief of Surgery at Brigham and Women’s Faulkner Hospital and the Associate Chair of Education at Brigham and Women’s Hospital. He is an Associate Professor in Surgery at Harvard Medical School and practices minimally invasive general surgery at both Brigham and Women’s and Brigham and Women’s Faulkner Hospitals. Dr. Smink is also the Program Director of the general surgery residency at Brigham and Women’s Hospital. He serves as the editor-in-chief of the Journal of Surgical Education and as a member of the editorial board of SCORE (the Surgical Council on Resident Education).
Gregory Snyder is a practicing clinician and physician innovator using technology to improve healthcare quality and experience. He is a graduate of Princeton University, Jefferson Medical College, the Brigham & Women’s Hospital Internal Medicine residency and Harvard Business School. He practices hospital medicine at Newton-Wellesley Hospital, Partners Healthcare. In addition to clinical practice, Gregory has worked with health technology startups to improve patient access to quality care. His research interests include primary care quality improvement, digital patient navigation across transitions of care, and home-based hospital care. Having worked with healthcare ventures in medication education and digital health, Gregory is now an advisor to Medically Home, a virtual ‘hospital at home’ platform for provision of acute care in patients’ homes. Greg has served as an advisor to Dialogue, a virtual-first primary and behavioral health care venture, and LuminDx, an AI diagnostic assistance application for primary care. Prior to medicine, Gregory worked in Public Health at a Guatemalan non-profit organization. He has explored his experience as a patient in a TED talk on patient-centered healthcare innovation, and advocates for training diverse groups of physician leaders.
I am a semi-retired Professor of Internal Medicine and Pediatrics at Albany Medical College, Albany NY, now residing in Jamaica Plain. I am a primary care physician for children and adults and teach evidence-based medicine and critical evaluation of the medical literature to our medical student and residents. My major area of research and publication is health-related judgment and decision-making, mostly in collaboration with health psychologists in France and Canada. I co-founded and coordinated the multi-disciplinary Capital District Medical Decision Making Interest Group, later the Health Care Value Forum; started the Capital District chapter of Physicians for a National Health Program; and served as President of the Hudson Valley district of the NY American College of Physicians. I have written on health care in France; have taught evidence-based medicine to students in Burkina Faso; and continue to participate in the medical advisory boards of the Engeye rural clinic in Uganda (at which I have worked three times, most recently in February 2020) and of Noora Health in India.
Joshua Sparrow is actively exploring two possible collaborations with Ariadne Labs: one with Dr. Katherine Semrau’s perinatal work as part of the BetterBirth Program, and one with the Serious Illness Care Program about using online simulation professional development tools for end of life health care provider and patient conversations.
Dr. Steve Spear, DBA, MS, MS is principal for HVE LLC, is award winning author of The High Velocity Edge, and is patent holder for the See to Solve Real Time Alert System. A Senior Lecturer at MIT’s Sloan School and a Senior Fellow at the Institute, Spear’s work focuses on accelerating learning dynamics within organizations so they know better faster what to do and how to do it. This has been informed and tested in practice in multiple “verticals” including heavy industry, high tech design, biopharm R&D, healthcare delivery and other social services, Army rapid equipping, and Navy readiness.
High velocity learning concepts became the basis of the Alcoa Business System—which led to 100s of millions in recurring savings, the Pittsburgh Regional Healthcare Initiatives “Perfecting Patient Care System”—credited with sharp reductions in complications like MRSA and CLABs, Pratt & Whitney’s “Engineering Standard Work”—which when piloted led to winning the engine contract for the Joint Strike Fighter, the operating system for Detroit Edison, and the Navy’s high velocity learning line of effort—an initiative led by the Chief of Naval Operations. A pilot with a pharma company cut the time for the ‘hit to lead’ phase in early stage drug discovery from twelve months to six.
Spear has published in Annals of Internal Medicine, Academic Medicine, Health Services Research, Harvard Business Review, Academic Administrator, and the US Naval Institute’s Proceedings. He invented the patented See to Solve Real Time Alert System and is principal investigator for new research on making critical decisions when faced with hostile data. He’s supervised more than 40 theses and dissertations. He holds degrees from Harvard, MIT, and Princeton and worked at the University of Tokyo, the US Congress Office of Technology Assessment and Prudential Bache.
Donna Spiegelman is one of the few people in the world with a joint doctorate in Biostatistics and Epidemiology. As a result, she can freely speak the languages of both disciplines, and switch between the two cultures, playing the role of interlocutor for either. She is the statistician for the Nurses’ Health Study 2, the Health Professionals Follow-up Study, the Pooling Project of Prospective Studies of Diet and Cancer in Men and Women, the Harvard PEPFAR Dar es Salaam site, Trials of Vitamins in Dar es Salaam, and the multitude of projects spawned by these efforts. Her research is motivated by problems which arise in epidemiology and require biostatistical solutions. Dr. Spiegelman’s website is one of the most visited at the Harvard T.H. Chan School of Public Health (HSPH), because it contains much user-friendly well-documented freeware implementing non-standard methods useful in epidemiologic research. Dr. Spiegelman’s most recent interest has been to work with various departments in an interdisciplinary effort to greatly increase global public health efforts at HSPH. In particular, Dr. Spiegelman is interested in developing, testing, and implementing preventive interventions to abate global cancer, diabetes and cardiovascular disease epidemics and offers her expertise in monitoring and evaluation to this end. Dr. Spiegelman and her doctoral student collaborate with BetterBirth through examining the use of pilot data to understand programmatic changes and “learning-by-doing” models of implementation science.
Ariel Dora Stern is the Poronui Associate Professor of Business Administration in the Technology and Operations Management Unit at Harvard Business School, where she teaches the MBA course “Transforming Health Care Delivery.” Ariel’s research focuses on innovation in health care. Her projects consider the regulation, strategy, and economics of health care, with a focus on understanding the drivers of new product development among firms and the determinants of how medical technologies are adopted and used in practice. Her research has been cited by Bloomberg, The New York Times, and National Public Radio. Ariel received her Ph.D. from Harvard, where she was a National Bureau of Economic Research Predoctoral Fellow in the Economics of Health and Aging. She holds an undergraduate degree in economics from Dartmouth College, where she was a Presidential Scholar and a two-time U.S. national collegiate figure skating champion.
Thomas C. Tsai, MD, MPH is an Assistant Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health and a member of the faculty in the Department of Surgery at Brigham and Women’s Hospital and Harvard Medical School. He is an associate faculty member of the Center for Surgery and Public Health, Ariadne Labs, and the Harvard Global Health Institute. His clinical practice focuses on bariatric surgery; surgical and endoscopic management of benign esophageal disorders, and abdominal wall reconstruction.
His research uses Medicare claims and other large datasets to study the effectiveness and unintended consequences of health policy interventions on the affordability, accessibility, and quality of health care in the United States. Current research projects leverage aggregated mobility data, claims data, and Census data to understand the effect of the COVID-19 pandemic on the US health care delivery system. His work has been profiled nationally and published in The New England Journal of Medicine, JAMA, Health Affairs, Lancet, Annals of Surgery, and JAMA Surgery.
During 2014-2015, he served as a Senior Advisor to the Assistant Secretary for Planning and Evaluation at the US Department of Health and Human Services, where he received the Secretary’s Distinguished Service Award. Dr. Tsai currently serves as the Vice-Chair of the Council on Graduate Medical Education. Dr. Tsai is a graduate of Harvard College. He received his M.D. from Stanford University School of Medicine, and a MPH from the Harvard T.H. Chan School of Public Health.
Dr. Vassy is an Assistant Professor of Medicine at Harvard Medical School, a clinician-investigator at the VA Boston Healthcare System (VABHS) and Brigham and Women’s Hospital (BWH), and a practicing primary care physician. He earned his MD degree from Washington University School of Medicine before completing his internal medicine residency at the University of Pennsylvania and a Harvard General Internal Medicine Research Fellowship at Massachusetts General Hospital. He directs the Genomes2Veterans research program at VABHS and BWH, and his research examines the clinical utility of genetic and genomic testing in various primary care clinical contexts. Current projects include clinical trials of pharmacogenetic testing, polygenic risk scores, and return of unanticipated genetic results.
Rebecca Weintraub, MD is an assistant professor in the Department of Global Health and Social Medicine at Harvard Medical School. Rebecca leads Better Evidence and the COVID-19 Vaccine Delivery at Ariadne Labs. Dr. Weintraub is a practicing internist and vaccinator.
At Ariadne Labs, Rebecca leads Better Evidence, with the aim of equipping frontline providers and trainees with vital digital tools at critical moments in health care delivery. Better Evidence serves 30,000+ front-line providers in more than 150 countries and 150+ medical schools and clinical sites. In the midst of the pandemic, Rebecca launched the Vaccine Delivery workstream of Ariadne Labs’ COVID-19 Response. Rebecca leveraged her previous research in Vaccine Delivery to build tools for leaders and the public to manage the uncertainty of the vaccine portfolio and the dynamic supply and demand. She continues to advise the Health and Human Service’s National Vaccine Advisory Committee, State leaders, Health entrepreneurs, and serves on the CONVINCE Steering Committee.
Rebecca was named a Young Global Leader by the World Economic Forum. Rebecca is a Health Innovator fellow of the Aspen Global Leadership Network. Dr. Weintraub graduated from Yale University, Stanford School of Medicine, and completed her medical training at Brigham and Women’s Hospital.
Roger Weiss served on the Ariadne Labs team that developed a physician checklist for better prescribing of opioids for people with chronic pain in order to create the proper balance of providing adequate pain treatment while reducing the risk of misuse and overdose. Developed for the Centers for Disease Control and Prevention, the tool guides primary care providers in a strategy that involves setting explicit goals for prescriptions, starting with brief trials first, stopping use when improvement in patient function with chronic pain is not achieved, and enabling regular reassessment. This checklist has rapidly entered wide use.
Dr. Weitberg serves as the Director of the Atrius Health Academic Institute where he oversees the development and implementation of all research and educational programs at Atrius Health. The Academic Institute is comprised of Centers for Clinical Research, Education, Analytics & Informatics and Healthcare Innovation. A major research interest of the Institute is redesigning care delivery to improve clinical outcomes, focus on patient-centered care innovation and reduce provider burnout by streamlining workflows. A multi-year project with IBM Watson Health is in progress to develop innovative tools in the workplace to reduce provider work burden while offering therapeutic options in real time. Multiple grant partners exist both locally and nationally in a variety of funded projects including medication adherence, telemedicine, childhood obesity, NLP research and Medically Home.
Chris Wong-Quiles collaborates with Ariadne Labs project “Making it Easier to Care for a Central Line at Home.” The project aims to reduce ambulatory CLABSI (Central Line Associated Bloodstream Infections) in pediatric hematology-oncology patients. They are doing this by developing a knowledge and skill development program that ensures that all caregivers in the home adhere to standardized care bundle and feel confident performing line care.
Zayed Yasin is the Assistant Director of the Division of International Collaborations in the Department of Emergency Medicine at the Brigham & Women’s Hospital. Dr. Yasin focuses on the intersection between Population Health and Acute Care Systems, and is currently working on projects to improve emergency care systems in Sweden and India.
Professor Steven Yule is an organizational psychologist and Chair of Behavioural Sciences at the University of Edinburgh. He is internationally recognized for his research on non-technical skills, patient safety, and simulation in surgery. Current research is funded by National Institutes for health (NIH) and National Aeronautics and Space Administration (NASA), focusing on the relationship between non-technical skills and patient outcomes, surgical safety in low and middle income contexts, coaching for performance enhancement, and mixed reality training for medical event management on long duration spaceflight. He recently returned to Scotland after eight years in Boston USA, where he served as Director of Research and Innovation at the STRATUS Center for Medical Simulation at Brigham & Women’s Hospital, and Associate Professor of Surgery at Harvard Medical School.
Michael Zalis serves as the chief medical officer of QPID Health, a medical informatics company based in Boston, MA. He is a board certified Radiologist with extensive experience in abdominal imaging, interventional radiology, computer science, and clinical research. Dr. Zalis continues to serve part-time as a staff member of Massachusetts General Hospital and as an associate professor at Harvard Medical School. Clinically, he serves on the abdominal imaging and interventional radiology services at MGH. He also currently direct the program in CT Colonography (aka “Virtual Colonoscopy”) at Massachusetts General Hospital; CT Colonography is a non-invasive method for colon cancer screening.